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1CHAPTER 1
General introduction
Respiratory diseases in poultry and
history of Ornithobacterium rhinotracheale
21. Aim and course of the studies described in this thesis
This thesis deals with an avian disease of the respiratory tract caused by a bacteri-
um named Ornithobacterium rhinotracheale. At the start of these studies almost not-
hing was known about the disease as well as about the bacterium and its effect on
poultry. In fact the bacterium was still nameless and only little information about the
clinical signs was on hand. The aim of these studies was to get a good picture of the
bacterium, the disease and a possible prevention of the disease. During the course of
the study several problems had to be solved and questions to be answered such as :
- The pathogenicity of O. rhinotracheale for poultry had to be established. The
infection route had to be investigated and infection models had to be developed.
- Growth conditions had to be established for the isolation of more field strains.
These were needed for further studies.
- Reliable identification methods for O. rhinotracheale, also suitable for use in rou-
tine laboratories, had to be developed.
- Serological tests had to be developed for screening and identification purposes.
- The proper biochemical and genetic methods to characterize strains had to be
selected.
- Searching for the possible reservoirs of the bacterium within the body, the course
of the O. rhinotracheale infection had to be investigated and the tools to do so had
to be developed.
- For the control of the disease, vaccines had to be developed and application routes
and vaccination schemes had to be investigated.
In this thesis the research work dealing with these items will be discussed.
2. Respiratory diseases in poultry
The globel spread of avian respiratory diseases is well described in the literature. In
addition to infectious agents (such as fungi, viruses, and bacteria), also environmental
circumstances e.g. high concentrations of ammonia play a role. The microorganisms
known to be involved in avian respiratory diseases are : Aspergillus species, laringotra-
cheïtis virus, infectious bronchitis virus, avian paramyxovirus types 1 (Newcastle disease
virus), 2, 3 and 6, influenza A virus, adenovirus group 1, reoviruses, pneumovirus,
Escherichia coli, Haemophilus paragallinarum, Pasteurella multocida, Riemerella
(Pasteurella) anatipestifer, Bordetella avium, Mycoplasma gallisepticum, Mycoplasma
synoviae, Mycoplasma meleagridis nd Mycoplasma iowae.
Not all of these agents have been proven to be primary pathogens, but their involvement
in respiratory diseases has been established. Most respiratory diseases are caused by
3more than one agent or a combination of an infectious agent and poor management
practices. Specially sanitation is an important factor in the prevalence of respiratory
diseases. These facts are complicating the establishment of pathogenicity of an infectious
agent.
2.a. Fungal respiratory pathogens
Aspergillus. The two major agents causing aspergillosis of poultry are Aspergillus
fumigatus and Aspergillus flavus (13). Symptoms of aspergillosis are dyspnea, gas-
ping, accelerated breathing, dermatitis, ophthalmitis and encephalitis. They occur in
almost all bird species. Airsacculitis with caseous nodules were found in turkeys after
an aerosol exposure of A. fumigatus. The disease resulted in 50% mortality (46).
Treatment is difficult because only a few drugs like Nystatin and Amphotericin B are
effective. Aspergillus species can be identified by the way the conidia (spores) are
formed. A. fumigatus forms greenish to gray conidia on uniseriate phialides up on the
upper two-thirds of the vesicle while A. flavus forms goldish to red brown conidia on
uniseriate and biseriate phialides covering the entire vesicle, pointing out in all directions
(32).
2.b. Viral avian respiratory pathogens
Adenoviruses of group 1. These viruses have frequently been isolated out of cases
of avian respiratory disease, but their role as primary infectious agents is questionable
(38). However, aerosol exposure did induce reactions in the air sacs (38). Quail bronchi-
tis virus is known to be pathogenic for quail, but not for other avian species (56). The
viruses have regularly been found together with other pathogenic agents but their role
as respiratory pathogen, except for quail bronchitis virus, is not well known. Because
of this normally no preventive measures are taken.
Infectious bronchitis virus (IBV) causes serous catarrhal or caseous exudates in
the trachea, the sinuses, the air sacs and the nasal passages which will result in gas-
ping, coughing, sneezing and nasal discharge. Infections occur in chickens and to a
lesser extent in turkeys and pheasants (28). All birds in a flock will become infected.
Mortality rates are usually low, only young birds will succumb (28). Mortality also
occurs when other agents, like bacteria, are present (15). There is no specific treatment
for IBV infections; vaccination is the best way to prevent the disease. Isolation and
serotype characterization of the isolates are necessary for a definitive diagnosis.
Serology can be performed with ELISA, Vero cell neutralization or haemagglutina-
tion inhibition (28).
4Influenza viruses of type A may cause respiratory, enteric or reproductive infections
(19). The severity is dependent on the virulence of the virus strain and the species,
age, environment and immune status of the birds. Morbidity and/or mortality can
reach up to 100%. Vaccination and eradication programs are used to control the disease.
There is no practical specific treatment available (6). Isolation and identification is
necessary for a conclusive diagnosis.
Laringotracheitis virus (LTV) causes nasal discharge, coughing, gasping, watery
eyes and conjunctivitis in chickens but not in turkeys (23). Morbidity rates can be
very high, while mortality rates varies (23). No drug has found to be effective against
LTV infections; vaccination is the only way to prevent the disease. Diagnosis is  done
serologically, usually using immunofluorescence (23).
Newcastle disease virus (NDV) causes a variety of clinical signs depending on
the virulence of the strain involved. In all cases the respiratory tracts are affected.
Chickens are highly (3), turkeys are less (1, 9) and ducks and geese are hardly suscepti-
ble (24). Morbidity and mortality rates in chickens can be very high. Often other
agents, like bacteria, are involved in the disease. The infectivity of the virus is reduced
by physical and chemical treatments but no treatment can guarantee the total inactivation
of the virus. Vaccination is the most important way to prevent NDV infections, but
also eradication programs are used to control the disease (3). Live vaccines may cause
reactions in the respiratory tract (8). Virus isolation is the only conclusive method for
diagnosis although immunohistological techniques can be helpful (22). NDV is also
known under the name paramyxovirus 1.
Paramyxoviruses other than NDV. Three other paramyxoviruses (PMV), the
types 2, 3 and 6, are able to cause mild respiratory infections and egg production
problems in chickens, turkeys and ducks. The mortality is low and prevention by
vaccination is only used in turkeys for PMV type 3 (3).
Pneumoviruses are the causitive agents of turkey rhinotracheitis (TRT) and swollen
head syndrome (SHS) in chickens (4). Also pheasants can be infected but pigeons,
ducks and geese are refractory. The signs of TRT in young turkeys are sneezing,
sniveling, conjunctivitis, swollen sinuses and foamy nasal discharge (34). In laying
birds also a drop in egg production can be seen. Morbidity of TRT is usually very
high, while mortality is variable and dependent on the presence of other infectious
agents (4). SHS infections cause swelling of the sinuses, depression and torticollis
with a low morbidity (39). Young birds appear to be more susceptible than older
animals. Protection can be obtained by vaccination using live and inactivated vaccines.
Treatment of TRT with antibiotics have been reported to be variably successful; this
success is presumably obtained by controlling secondary bacterial infections(16). Vi-
rus isolation, although difficult, and serology are the best ways for diagnosis.
5Reoviruses are associated to arthritis and tenosynovitis. They were also associated
with acute and chronical respiratory syndromes in chickens, turkeys and other avian
species (49). The primary respiratory pathogenicity of reoviruses is not well known
but the role as secundary pathogens has been confirmed (48). Vaccination has been
proven to provide protection. Virus isolation is the best way for diagnosis.
2.c. Bacterial avian respiratory pathogens
Bordetella avium is the causative agent of turkey coryza (TC), an infection in
turkeys which also occurs, but in a less severe form, in chickens (5). TC causes
sneezing, coughing, a clear nasal discharge, mucoid exudate in the upper trachea and
softening of the trachea. High morbidity together with low mortality is a typical fin-
ding of TC. Contact and litter or water contamination are the most common routes of
infection (52). Vaccination with bacterins as well as live vaccines is useful for
prevention. High doses of penicillin together with oxytetracycline in the drinking wa-
ter for at least 3 days has been proven to be a good treatment (26). Other antibiotics
normally will not cure the disease (5). B. avium, formerly Alcaligenes faecalis (27), is
a gram-negative, motile, small, strictly aerobic rod that grows well on standard media
and on some selective media such as McConkey agar (37).
Escherichia coli. E  coli, most of the time in combination with viruses or Myco-
plasma species, is the causative agent of a disease called air sac disease or chronic
respiratory disease (CRD). CRD has been reported in chickens, turkeys and ducks
(20). The clinical picture of CRD is characterized by thickened air sacs with caseous
exudate, pericarditis usually associated with myocarditis, perihepatitis and occasionally
salpingitis (20). Mortality occurs during the first week of the infection. Mortality
rates can be very high. Specially when other pathogenic factors, such as infections
with IBV, NDV or Mycoplasma, are involved, the disease can cause severe losses.
Egg transmission has been found to be important way of for the spread of the infection
(20). Usually CRD can be treated effectively with the common antibiotics, but a number
of avian isolates of E. coli are  resistant to one ore more drugs (20). Vaccination has
been proven to be an effective way of prevention (20). E. coliis a gram-negative,
motile, facultative anaerobic, pleomorphic rod from the family Ent robacteriaceae
that grows rapidly in standard media and on some selective media as McConkey agar
(7).
Haemophilus paragallinarum. Infectious coryza (IC), caused by H. paragallina-
rum, is only found in chicken and quails, not in turkey, pigeon or duck (57). The
disease is characterized by an acute catarrhal inflammation of the mucous membranes
of the nasal passages and sinuses. Also subcutaneous edema of the face and the watt-
6les and catarrhal conjunctivitis are common. Pneumonia and/or air sacculitis are rarely
present. When not complicated by infections with other agents such as respiratory
viruses (e.g. NDV or IBV) or Mycoplasma, IC will hardly result in an increased
mortality (57). Airborne transmission is believed to be the most common infection
route. Bacterin vaccines do protect, although immunity is serovar-specific. Live
vaccines induce better cross-protection (47). Treatment of IC with antibiotics is difficult
because most of the therapeutic agents are not bactericidal. Also drug resistance
developes rapidly. Only combinations of drugs (e.g. sulfanomides with trimethoprim)
are effective (35,36). H. paragallinarum is a gram-negative, non-motile, facultative
anaerobic, pleomorphic rod from the family Pasteurellaceae that needs the reduced
form of NAD (NADH) and, sometimes, serum for growth (57). However pathogenic
strains of H. paragallinarum which were NADH- and serum-independent have been
reported, predominantly from South Africa.
Mycoplasmata. Avian mycoplasmosis is caused by the four most common avian
Mycoplasma species : M. gallisepticum, M. synoviae, M. meleagridis and M. iowae.
The disease is characterized by high morbidity and low mortality. M. gallisepticum
causes air sacculitis, severe sinusitis and tenovaginitis in turkeys and chickens (59).
M. synoviae causes air sacculitis, sinovitis, body-weight loss and lameness in chickens
and turkeys (29). The lameness is caused by inflammation and swelling of the joints.
M. meleagridis causes air sacculitis and skeletal abnormalities in turkeys but not in
chickens (58). M iowae causes mild air sacculitis and lesions in the leg in turkeys and
chickens (30). Egg-transmission as well as contact and airborne droplets have found
to be infection routes. Bacterins and live vaccines are be effective for protection. The
succes of treatment of Mycoplasmosis is dependent on the species involved. Not all
species are susceptible to the commonly used antibiotics. Egg dipping and injection
with Tylosin is effective for infections with M. gallisepticum, M. synoviae and M.
meleagridis (29, 58, 59). Mycoplasmas are the smallest free living micro-organisms.
They lack a cell wall and need protein-rich media containing at least 10 to 15% animal
serum (31). M. synoviae also needs NAD for growth (31). Growth is slow and is on
solid media marked by typical “fried-egg” colonies. Mycoplasmas are resistant to
penicillin and thallium acetate. These compounds are incorporated into media to supress
growth of other bacteria (31).
Pasteurella multocida. Fowl cholera (FC) is caused by P. multocida nd is pre-
sent in many avian species (45). FC is of historical importance because it is the first
bacterial disease investigated for which a vaccine was developed (43). The clinical
picture of FC does often, but not always, include respiratory infections. Virulent strains
cause acute FC, which is featured by fever, anorexia, strong mucous discharche from
the mouth, diarrhea and an increased respiratory rate. These signs occur within a day
7before death, which is caused by sepsis (42). Chronic FC, caused by less virulent
strains, shows signs generally related to localized infections e.g. in the wattles, foot
pads, joints and the respiratory tract (45). Free-flying birds and chronically infected
birds are considered to be the source of infection. Vaccination with bacterins induce
serovar-dependent protection (unpublished observations). Live vaccines induce better
cross-protection but often have residued pathogenicity. Acute FC is very hard to treat.
Only high doses of antibiotics e.g. Streptomycin, given intramuscularly just before or
at the time of inoculation of P. multocida in experimental challenge studies, can prevent
death (45). The efficacy of the treatment of chronic FC is dependent on the sensitivity
of the strain involved because P. multocida strains strongly vary in susceptibility to
antibiotics (45). P. multocida is a gram-negative, non-motile, small, facultative
anaerobic rod from the family Pasteurellaceae which grows rapidly on standard me-
dia but not on selective media such as McConkey agar (7).
Riemerella anatipestifer, o mely Pasteurella anatipestifer (51), infects ducks,
turkeys, geese and pheasants but, not chickens or pigeons (50). The infection causes
ocular and nasal discharge, mild coughing and sneezing and ataxia. Tremors of the
neck and head are found to be typical for R. natipestifer infections. Mortality does
vary from minor  to moderate, depending on predisposing factors such as adverse
environmental conditions and other diseases. How R. anatipestifer infects birds is not
clear, but small wounds and air-born droplets are believed to play a role. Experimentally
the disease can be reproduced by injection, but not by oral application (50). Treatment
with antibiotics is difficult because strains of R. anatipestifer differ strongly in their
sensitivity patterns. Usually sulphonamides will effective. Vaccination can be an
effective way to prevent the disease, but immunity is serovar-specific (50). R. anatipes-
tifer is a gram-negative, non-motile, small, facultative anaerobic rod from the family
Pasteurellaceae which grows rapidly on standard media but not on selective media as
McConkey agar (7).
3. History of Ornithobacterium rhinotracheale
In 1991 a new respiratory disease in broiler chickens was observed in South Africa
by Jan DuPreez (53). Relatively mild respiratory symptoms, which started with snee-
zing at an age of about 28 days and which lasted up to the end of the fattening period,
were accompanied by increased mortality (3 % more) and poor performances
considering e.g. growth per day and feed conversion. At post mortem investigation
foamish, white, “yoghurt like” exudate in the air sacs, predominantly in the abdominal
air sac, was the most striking feature; also pneumonia was described. Bacteriological
examination revealed a slow growing, pleomorphic, gram negative rod, which could
8not be classified as one of the known bacterial species.
A Pasteurella-like bacterium, isolated from ducks suffering from a respiratory
disease in Hungary in 1987, proved to be identical to the South African isolates in
appearance as well as biochemically. Also R. anatipestifer-like isolates from turkeys
suffering respiratory disease isolated in Germany in 1991 and 1992 (21) looked identical
and had the same biochemical reactions as the strains from South Africa and Hungary.
In several turkey flocks in the Netherlands and Germany, clinical findings like
sniveling, sneezing, wet eyes and swelling of the sinus infraorbitalis, together with
severe growth retardation were detected in 1992 and 1993 (53). On some farms there
was a constant increase of mortality despite medication. Also in broilers, minor to
moderate respiratory problems and acute deaths were observed. These clinical findings,
starting at 2 to 8 weeks of age in turkeys and at 2 to 5 weeks of age in broilers, were
characterized in turkeys by a severe purulent pneumonia (53). These features resembled
the features of a P. multocida-infection, but occurred at a very young age. In the field
it was found that even at 2 weeks of age airsacculitis (upper and lower air sacs) and
pericarditis could be detected in turkeys as well as chickens (53). Out of tissues from
affected animals gram-negative rods, similar to the strains out of South Africa, Germany
and Hungary, were be isolated.
In turkeys conventional oral therapeutics gave poor results. Especially when
pneumonia was prevalent, the use of e.g. enrofloxacine and trimethoprim +
sulphonamide was hardly or not at all effective. Occasionally injections with
tetracyclines and synthetic penicillins (usually twice) were effective. In other cases
medication failed, resulting in losses of up to 25% within a few weeks (21, 53). Isolated
strains out of these cases in the Netherlands were almost all resistant to flumequine,
only slightly sensitive for enrofloxacine and trimethoprim + sulphonamide and sensitive
for tetracyclin and ampicillin. A German investigation (Hafez, personal communication)
showed that 90% of the German strains were resistant to enrofloxacin and all were
resistant to trimethoprim + sulphonamide, while all strains were sensitive for tetracyclins
and amoxycillin.
The isolation of Pasteurella-like bacteria from six meat turkeys flocks with respira-
tory disease in Germany was reported (21). Also in the U.S.A. these pleomorphic
gram-negative rods, associated with avian respiratory disease, were isolated from
turkeys and chickens in California (12). Finally, bacteria isolated from a Dutch turkey
flock with respiratory problems in 1992, initially defined as R. anatipestifer were
found to be similar. Not all the strains, mentioned in these reports, did serologically
react with antisera against the strains from South Africa, Germany and Hungary but
the appearance, the odor and the biochemical reactions of all strains were identical.
Initially the new bacterium was named Pasteurella-like or Kingella-like. Later on
9Bisgaard stated that the organism could be classified within a group of bacteria
designated as TAXON 28. In 1994 the name Or ithobacterium rhinotracheale g n.
nov. sp. nov. was proposed for this new species (54). By nows all the above mentioned
strains have been classified as O. rhinotracheale.
Investigations of culture collections in Germany, revealed that O. rhino racheale
already had been isolated from the respiratory tract of turkeys in 1981 and of rooks in
1983. Also in Belgium, France and Israel O. rhinotracheale had been isolated before
1990 (54). Sofar no isolates of O. rhinotracheale from before 1981 have been repor-
ted. After improving the isolation method of avian respiratory bacteria, the presence
of O. rhinotracheale was found to be linked to air sacculitis and purulent pneumonia
in meat turkeys and broiler chickens (17, 18, 33, 40, 41, 53, 54). In various areas in
the U.S.A. O. rhinotracheale was associated with acute pneumonia with mortality
rates from 2 - 50% in older turkeys (12 weeks or older) in 1995 and 1996 (6). More
recently O. rhinotracheale was shown to be connected to high losses in broiler chickens
of 28 days and older (10). In these cases a subcutaneous oedema over the cranium
with a severe bacterial osteitis, but without an infection of the respiratory tract was
found.
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Experimental infection in turkeys and
chickens with Ornithobacterium
rhinotracheale
Paul van Empel, Han van den Bosch,
Danny Goovaerts and Paul Storm
Avian Diseases 40: 858-864, 1996
SUMMARY
Ornithobacterium rhinotracheale was found to cause growth retardation in both
turkeys and chickens after experimental intra air sac administration and to cause
growth retardation together with airsacculitis and pneumonia after aerosol administra-
tion. Both turkey and chicken isolates of O. rhinotracheale were able to induce the
same kind of respiratory inflammations and weight-gain losses in chickens as well
as turkeys. Turkey rhinotracheitis virus was found to have a triggering effect on the
O. rhinotracheale infection in turkeys while Newcastle disease virus and to a lesser
extent Infectious Bronchitis virus showed triggering effects on the O. rhin tracheale
infection in chickens. O. rhinotracheale could be reisolated from affected organs of
experimentally infected birds.
INTRODUCTION
Only very recently a pleomorphic gram-negative rod-shaped bacterium was
isolated in various countries from turkeys and chickens with respiratory disease
(1,4,5). These bacteria could not be classified as belonging to an already known
species, and subsequently a new taxon Ornithobacterium rhinotracheale g n. nov.,
sp. nov. was proposed (6). The clinical symptoms associated with the isolation of O.
rhinotracheale included weakness, gasping, severe dyspnoea, mucus discharge and
mortality (1,4). Dissection showed fibrinopurulent pneumonia and fibrinous
inflammation of the thoracic air sacs (1,4,5).
In the present paper we describe experimental infection of turkeys and chickens
with isolated and pure cultures of O. rhinotracheale in order to reproduce the
respiratory disease seen in clinical outbreaks. Furthermore, the possible triggering
effect of various respiratory viruses on the outcome of experimental O. rhinotracheale
infection was investigated.
MATERIALS AND METHODS
Bacterial strains. The two strains used for this study were O. rhinotracheale
strain B3263/91, isolated from a diseased broiler chicken in South Africa by J.H.
duPreez and strain GGD-1261, isolated from an affected fattening turkey in Germany
by H.M. Hafez. Both strains were maintained lyophilized at -20°C. Bacteria were
grown at 37°C on sheep blood agar plates in a 5-10% CO2 atmosphere, or in brain-
heart infusion broth (BHI, Oxoid) at 37°C. When grown on bloodagar for at least 48
hr, O. rhinotracheale colonies appeared tiny, grey to grey-white, sometimes with a
reddish glow, and had a distinct odor related to butyric acid.
Viral strains. Turkey rhinotracheitis (TRT) virus strains 3B OC21 (turkey
challenge strain) and SA-2381-88/OC20 (isolated out of diseased broiler chickens in
South Africa) both were obtained as frozen virus suspensions from J. Cook (Intervet
UK Ltd, England). The Newcastle Disease (ND) virus strain used was a lentogenic
strain LaSota as described by Goldhaft (3). The Infectious Bronchitis (IB) virus
strain used was a clone derived from Mild Mass H, belonging to the Massechussetts
serotype.
Experimental animals. The chickens used were commercial Hybro-broilers (Inter-
broed, Gemert, The Netherlands), and fattening turkeys used were commercial British
United Turkeys (BUT) animals (Plukon, Ruinen, The Netherlands). Both broilers
and turkeys were purchased as embryonated eggs, and housed in isolaters immediately
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after hatching. Food (Hendrix’ voeders, Heijen, The Netherlands) and water were
given ad libitum.
Intra-air sac challenge. For intra-air sac challenge, the bacterial strains were
first passed through eggs. Bacteria were harvested from blood agar plates in 0.04M
posphate-buffered saline (pH = 7.2) and inoculated into the yolk sac of 7-9-day-old
embryonated eggs. The eggs were incubated until embryo death, which mostly
occurred within 2 days. Subsequently, yolks were collected and stored at -20°C. For
challenge, 0.2 ml of infected yolk, containing 4.2 x 108 colony-forming units (CFU)
of strain B3263/91 or 7.5 x 108 CFU of strain GGD-1261, was injected per bird
directly into the right abdominal air sac.
Aerosol challenge. For aerosol challenge, the bacterial strains were grown in
BHI for 24 h at 37°C with agitation. In each isolator (approximately 1.5 m3), containing
the birds to be challenged, 100 ml of O. rhinotracheale culture with 108-109 C.F.U.
per ml was administered as a fine spray using a commercial paint sprayer. The
developed mist was maintained in the isolators for at least 10 min. with the air
circulation closed.
Virus infection. In a number of experiments, birds were infected with virus 5-6
days prior to O. rhinotracheale a rosol challenge. Turkeys were infected with a cul-
ture of TRT virus strain 3B OC21 containing 106.6  median ciliostatic doses (CD50)
per ml, by administering 0.1 ml intranasally and 0.1 ml by eye drop (2). Broiler
chickens were infected with either a culture of TRT virus strain SA-2381-88/OC20
containing 104.5 CD50 per ml by administering 0.1 ml intranasally and 0.1 ml by eye
drop, or by a coarse spray of a culture of IB virus containing at least 106 median egg
infective doses (EID50) per bird, or a coarse spray of a culture of ND virus strain
Lasota containing at least 106 EID50. The coarse spray method was performed accord-
ing to the method described by Yadin and Orthel (7) using an Hazelock ASL
polysprayer 4075 (Louis Blok B.V., Hoevelaken, The Netherlands).
Parameters of infection. During 7 to 14 days after O. rhinotracheale challenge,
morbidity and mortality were recorded, the daily weight gain after challenge was
determined, macroscopical lesions were recorded at postmortem examination of the
birds, and attempts to reisolate the challenge bacteria were carried out. At postmor-
tem examination a scoring system for the observed lesions was used as follows : for
thoracic air sacs, 0 = no abnormalities, 1 = one air sac seriously affected by fibrinous
airsacculitis or limited pin-head sized foci of fibrinous exudate in both air sacs, 2 =
both air sacs seriously affected by fibrinous airsacculitis; for abdominal air sacs, 0 =
no abnormalities, 1 = pin-head sized foci of fibrinous exudate or slight diffuse fibrinous
airsacculitis, 2 = severe fibrinous airsacculitis; for lungs, 0 = no abnormalities, 1 =
unilateral pneumonia, 2 = bilateral pneumonia; for trachea, 0 = no abnormalities, 1 =
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some exudate in the tracheal lumen, 2 = lumen of the trachea filled with exudate. All
data were presented as percentages of the maximal possible lesion scores per group.
Statistical analysis. The statistical analyses for the weights and weight gains
were performed by using Student’s t-t s  (single sided). The statistical analyses for
the pathologic lesions were performed by using the Kruskal-Wallis one-way analysis
of variance.
RESULTS
Intra-air sac challenge. The intra-air sac challenge of 32 days old turkeys with
both O. rhinotracheale strains B3263/91 or GGD-1261 resulted in a significant
decrease of the daily weight-gain during the 11-day observation period (Table 1).
Table 1. Intra air-sac challenge in turkeys at 32 days of age with O. rhinotrac eale
strains B3263/91 and GGD-1261
Challenge Average weight (g) Average daily
strain n Age 32 days Age 43 daysA weight gain (g)A
Control 6  992 (± 58) 1889 (± 87)a 82 (± 6)a
B3263/91 8 1011 (±141) 1731 (±217)b 65 (±8)b
GGD 1261 8 1044 (±117) 1657 (±220)b 56 (±11)b
A Within columns, averages having different superscripts are significantly different
(P<0.05)
Table 2. Intra-air sac challenge in broilers at 31 days of age with O. rhinotrac eale
strains B3263/91 and GGD-1261
Challenge Average weight (g) Average daily
strain n Age 31 days Age 41 daysA weight gain (g)A
Control 10 1323 (± 127) 1988 (± 287)a 60 (± 14)a
B3263/91 10 1409 (± 109) 1735 (± 303)b 30 (± 23)b
GGD 1261 10 1356 (± 122) 1816 (± 178)b 42 (±   9)c
A Within columns, averages having different superscripts are significantly different
(P<0.05)
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Mortality or clinical symptoms were not observed after challenge, and macroscopic
lesions were absent at autopsy. Furthermore, the challenge bacteria could not be
reisolated from the airsacs. The only sites from which O. rhinotracheale could be
isolated were the brains (occasionally) and the heel joint (when inflamed). Similar
results were seen after intra-air sac challenge of 31-day-old broiler chickens. Thus a
significant growth retardation was the predominant effect (Table 2).
Aerosol challenge of turkeys. Turkeys challenged with an aerosol of O. rhinotra-
cheale strain B3263/91 at 14 days of age showed severe airsacculitis at 7 days post
challenge, but no growth retardation. When TRT virus was administered to 8-day-
old turkeys prior to O. rhinotracheale challenge 6 days later, a significant growth
retardation was seen, together with the induction of severe airsacculitis (Table 3).
Table 3. Aerosol challenge of turkeys with Ornithobacterium rhinotracheale (O.r.)
strain B3263/91, using turkey rhinotracheitis (TRT) virus strain 3B/OC21 as a trigger.
TRT administration was at 8 days, O. rhinotracheale challenge was at 14 days, and
post mortem investigation was at 21 days of age.
        Challenge Average daily Airsacculitis as a %
TRT O.r. n weight gain (g)AB of the maximum scoreB
NO NO 10 27 (±  4)a 0a
YES YES 10 21 (±  4)b 81b
NO YES 10 30 (±  4)a 92b
YES NO 10 26 (±  4)a 0a
A Daily weight gain measures between day 1 and day 21
B Within columns, average and percentages having different superscripts are
significantly different (P<0.05)
When 31-day-old turkeys were challenged with O. rhinotracheale significant growth
retardation was induced, but growth retardation was accompanied by a significant
increase in the airsacculitis score only when TRT virus was administered prior to O.
rhinotracheale challenge (Table 4). Administration of TRT virus alone at an earlier
or later age induced only very mild airsacculitis and no decrease in growth rate
(Tables 3, 4). Using an aerosol challenge of turkeys, with or without the prior
administration of TRT virus, neither mortality nor clinical symptoms could be induced
and no other pathologic lesions developed apart from airsacculitis. The challenge
bacteria could be reisolated from the affected air sacs, but isolation from any other
nonaffected organ remained negative.
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Table 4. Aerosol challenge of turkeys with Ornithobacterium rhinotracheale (O.r.)
strain B3263/91, using turkey rhinotracheitis (TRT) virus strain 3B/OC21 as a trigger.
TRT administration was at26 days, O. rhinotracheale challenge was at 31 days, and
post mortem investigation was at 42 days of age.
        Challenge Average daily Airsacculitis as a %
TRT O.r. n weight gain (g)AB of the maximum scoreB
NO NO 10 102 (± 16)a 3a
YES YES 10 54 (± 9)b 27b
NO YES 10 57 (± 11)b 15bc
YES NO 10 100 (± 18)a 11ac
A Daily weight gain measured between day 31 and day 42
B Within columns, averages and pathologic scores having different superscripts are
significantly different (P<0.05)
Aerosol challenge of broilers. In two separate experiments broiler chickens were
challenged at an age of 14 days (Tables 5, 6) or 21 days (Tables 7, 8) with an aerosol
of O. rhinotracheale strain B3262/91 and observed for 2 wk after challenge. A signi-
ficant decrease in daily-weight gain was seen, especially in the second week after
challenge (Tables 6, 8). Pathologic lesions at postmortem investigation in general
were mild, with only significant airsacculitis at 1 wk after challenge and, in one of
the experiments, severe exudate in the trachea at 2 wk postchallenge.
As shown in Tables 5 and 6, the administration of IB virus and, to a lesser extent,
TRT virus, at 5 days before O. rhinotracheale challenge had an aggravating effect,
especially on the development of airsacculitis. As shown in Tables 7 and 8, the
administration of ND virus at 5 days prior to O. rhin tracheale challenge induced a
more serious increase of airsacculitis and pneumonia scores, as compared with both
O. rhinotracheale challenge or ND administration alone. As in turkeys, especially in
the right abdominal air sacs, severe fibrinous inflammation was found. The airsaccu-
litis consisted of a foamy exudate with presence of relatively large clots of fibrin
(Figure 1). In most cases the pneumonia was unilateral with a clear boundary bet-
ween the affected and healthy part of the lung (Figure 2). Mortality or clinical
symptoms were absent. The challenge bacteria could easily be reisolated from the
organs with macroscopical lesions and from tracheal exudate but not from any other
non-inflamed organ.
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Table 5. Aerosol challenge of broilers with Ornithobacterium rhinotracheale  str in
B3263/91, using an infectious bronchitis (IB) virus Massechusetts serotype strain
and turkey rhinotracheitis (TRT) virus strain SA-2381-88/OC20 as triggers. Virus
administration was at 9 days, O. rhinotracheale challenge was at 14 days and post
mortem investigations was at 21 days of age.
Average daily weight gainPathologic lesions
between days 14 and 21(as a % of the maximal score)
Challenge n weight gain (g)A n Air sacsA Trachea A Lungs
Control 20 52  (±  6)a 10  0a  0a   0
O.r. 20 50  (±  8)a 10 18b  5a   0
IB and O.r. 20 46  (±  8)b 10 45c 20b 10
TRT and O.r. 19 54  (±  6)a 10  28bc  10ab   0
A Within columns, averages and pathologic scores having different superscripts are
significantly different (P<0.05)
Table 6. Aerosol challenge of broilers with Ornithobacterium rhinotracheale str in
B3263/91, using an infectious bronchitis (IB) virus Massechusetts serotype strain
and turkey rhinotracheitis (TRT) virus strain SA-2381-88/OC20 as triggers. Virus
administration was at 9 days, O. rhinotracheal challenge was at 14 days and post
mortem investigations was at 28 days of age.
Average daily Pathologic lesions
weight gain between (as a % of the maximal score)
Challenge n days 14 and 28A Air sacsA Trachea A Lungs
Control 10 56  (±  8)a   0a   0a 0
O.r. 10 43  (±  6)b 5a 60b 0
IB and O.r. 10 44  (±  7)b 23b 5a 0
TRT and O.r. 9 51  (±  7)a 20b   0a 0
A Within columns, averages and pathologic scores having different superscripts are
significantly different (P<0.05)
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Table 7. Aerosol challenge of broilers with Ornithobacterium rhinotracheale
(O.r.) strain B3263/91, using Newcastle disease (ND) virus strain LaSota as trigger.
ND administration was at 16 days, O. rhinotracheale challenge was at 21 days, and
postmortem investigation was at 28 days of age.
Average daily weight gainPathologic lesions
between days 14 and 28(as a % of the maximal score)
Challenge n weight gain (g)A n Air sacsA Trachea A Lungs
Control 24 52 (± 9)a 10    3a   0 0a
O.r. 25 41 (± 5)b 10 25b   5 10a
ND 24 39 (± 7)b 10 15b   0 0a
ND and O.r. 25 43 (± 7)b 10 80c 10 75b
A Within columns, averages and pathologic scores having different superscripts are
significantly different (P<0.05)
Table 8. Aerosol challenge of broilers with Ornithobacterium rhinotracheale (O.r.)
strain B3263/91, using Newcastle disease (ND) virus strain LaSota as trigger. ND
administration was at 16 days, O. rhinotracheale challenge was at 21 days, and post-
mortem investigation was at 35 days of age.
             Average daily weight Pathologic lesions
                                        gain between days           (as a % of the maximal score)
Challenge  n 21 and35A 28 and 35A Air sacsA Trachea A Lungs
Control 14 59 (±  8)a 66  (±  8)a  0a  0a  0
O.r. 15 26 (±  3)b 11  (±  5)b  2a  0a  0
ND 14 46 (±  7)c 54 (± 12)c 14b 21b  0
ND and O.r.15 43 (±  5c 42  (±  7)d 70c  3a  0
A Within columns, averages and pathologic scores having different superscripts are
significantly different (P<0.05)
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Figure 1: Airsacculitis of the abdominal air sacs of a 28 days old broiler, showing
a foamy exudate with large clots of fibrin (arrows). The bird was challenged with an
aerosol of Ornithobacterium rhinotracheale at 21 days of age after the administration
of Newcastle disease strain LaSota at 16 days of age.
Figure 2: Unilateral pneumonia in a 28 days old broiler, showing a clear boundery
between the affected and healthy part of the right lung (arrow) and the not infected left
lung. The bird was challenged with an aerosol of Ornithobacterium rhinotracheale at 21
days of age after the administration of Newcastle disease strain LaSota at 16 days of age.
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DISCUSSION
In this study we showed that experimental infection of both turkeys and broilers
with O. rhinotracheale bacteria could evoke respiratory disease, with at least partly
the same characteristics as seen in clinical outbreaks. Both a turkey and a broiler O.
rhinotracheale isolate induced growth retardation in turkeys as well as in broiler
chickens after intra-air sac challenge without macroscopical lesions. The O.
rhinotracheale strain isolated from a diseased broiler was used for aerosol challenge
of both turkeys and broilers of various ages, and was capable to induce airsacculitis
and/or growth retardation. In turkeys, infection appeared to be aggravated by the
prior administration of a turkey TRT virus isolate. In broilers, infection appeared to
be aggravated by the prior administration of ND virus, and to a lesser extent by prior
administration of IB virus or a chicken TRT virus isolate, in particular with regard to
development of airsacculitis and pneu-monia.
The most prominent clinical sign after experimental infection appeared to be the
growth retardation. Also, in clinical outbreaks in the field a decreased feed and wa-
ter intake was associated with the isolation of O. rhi otracheale (4, van Empel, pers.
obs.). However, other clinical signs seen in outbreaks such as weakness, dyspnoea,
mucus discharge and even mortality (4,5), were not observed after experimental
infection. This seeming discrepancy between natural and experimental O. rhino-
tracheale infection might be explained by differences in predisposing and aggravating
factors. In the present study we showed that infection was aggravated by prior adminis-
tration of certain avian viruses. But under field conditions also other factors can be
of importance such as stress, high stock density, poor ventilation, presence of other
bacteria, or high ammonia levels.
With regard to pathology, the most prominent lesion after experimental O.
rhinotracheale infection was the development of fibrinous airsacculitis, sometimes
accompanied by pneumonia or tracheal exudate. These postmortem features were
also observed in clinical outbreaks associated with the isolation of O. rhinotracheale
(1,4,5; van Empel, pers. obs.). Although not all clinical signs and postmortem findings
as seen in clinical outbreaks could be reproduced after experimental O. rhinotracheale
infection, we nevertheless feel that the present study demonstrates that O.
rhinotracheale is a true infectious agent in turkeys and broiler chickens. All three
postulates of Koch are fulfilled : the agent was isolated from diseased birds and not
from healthy birds (1,4,5; this study); the agent was grown to purity; and the pure
agent was able to reproduce the disease in turkeys and broilers after experimental
infection and the agent was recovered from the diseased animal (this study).
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In this study a turkey and a broiler isolate of O. rhin tracheale were used. Both
strains appeared to have the same effects in turkeys as well as broilers after
experimental infection. Therefore, we conclude that so far no clonal pathogenicity
exists among O. rhinotracheale strains for either turkeys or broiler chickens, but that
strains are equally able to infect various avian species. But, of course, further re-
search will have to provide more answers to the many remaining questions regarding
this new avian respiratory disease.
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SUMMARY
In the present study 443 strains of Or ithobacterium rhinotracheale, a causative
agent of respiratory disease in fowl, were investigated biochemically and serologi-
cally. In both ways O. rhinotracheale could be differentiated from other gram-negative
rods and, more particularly, from the Pasteurella-like bacteria potentially pathogenic
for fowl. For the biochemical characterisation of O. rhin tracheale the API-20NE
identification strip proved to be useful, although O. rhinotracheale is not included in
the API system.
Serologically, by using monovalent antisera in agar gel precipitation (AGP) tests
and enzyme-linked immunosorbent assays (ELISAs), seven serotypes (serotypes A
to G) of O. rhinotracheale could be discriminated. The AGP test was chosen as the
preferred method to be used for serotyping. Isolates of serotype A was found to be
the most prevalent, especially in chickens. Isolates from turkey were more
heterogeneous devided over the serotypes. Some strains showed cross-reactivity
between the serotypes A, B and E. Five O. rhinotracheale strains could not be sero-
typed with the available antisera. Relationships between the geographic origin and
the serotypes were found. By the ELISA the presence of antibodies against O. rhino-
tracheale could be detected in 1-day-old birds as well as in birds with clinical signs,
and therefore, it might be useful for diagnostic purposes.
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INTRODUCTION
Respiratory problems, together with purulent pneumonia, airsacculitis, severe
growth retardation and rapidly increasing mortality were reported in meat turkeys
and broilers in South Africa, Germany, the United States, France and the Nether-
lands (1, 2, 4 and 6). A gram-negative, pleomorphic rod, could repeatedly be isolated
from affected organs. This Pasteurella-like organism has recently been referred to as
Ornithobacterium rhinotracheale g n. nov. sp. nov. (7). In experimental infections,
it was possible to evoke severe growth retardation and airsacculitis in turkeys and
chickens with this bacterium (8). O. rhinotracheale strains from different countries
reporting fowl infected with the organism were investigated for their bacteriological,
biochemical and serological relationships and their differences from other gram-
negative rods.
MATERIALS AND METHODS
Bacterial strains. The 443 O. rhinotracheale strains, involved in this study, were
isolated between 1987 and 1996 from the respiratory tract, liver, joints or brain of
diseased birds in various countries. All except three strains were isolated from chickens
or turkeys; the other three strains were isolated from a duck (from Hungary), and
from a guinea fowl and a partridge (both from France). Immediately after arrival the
strains were freeze-dried and stored at -20°C. The strains were cultivated on sheep
blood agars at 37° C, in a 5 to 10 % CO2 atmosphere for at least 48 hours.
For comparative investigations, the 16 serotype-specific strains of Pasteurella
multocida (3), the 17 serotype-specific strains of Riemerella anatipestifer (5) and
the 3 serotype-specific strains of Haemophilus paragallinarum (9) together with 2
NADH-independent H. paragallinarum strains from South Africa (J. du Preez) and
a fieldstrain ofPasteurella gallinarum (our own collection) were used. Because in
the beginning we found O. rhinotracheale to react biochemically as a Kingella-like
bacterium, the strains Ki gella kingae ATCC 23330, Kingella denitrificans ATCC
33394 and Kingella (Suttonella) indologenes ATCC 25869 were included in the
comparative studies.
Biochemical and enzymatic reactions. The biochemical and enzymatic reactions
were tested using the A.P.I. system (BioMérieux SA, La Balmes-Les Grottes, France).
All tests were performed under the prescribed conditions. As in the identification
method used by the API system, O. rhinotracheale strains, which are oxidase-positive,
gram-negative, facultatively anaerobic rods, were characterised with use of the API-
20NE strip.
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Serological investigations. Monovalent antisera were prepared by injecting
specific-pathogen-free chickens subcutaneously twice, with a bacterin containing
between 108 and 109 formalin-killed bacteria per dose in an oil adjuvant at an inter-
val of 3 to 4 weeks. At 3 to 4 weeks after the second injection, serum was collected.
Boiled extract antigens (BEAs) were prepared as described by Heddleston (5) by
washing well-grown cultures from sheep blood agar with 0.02 M Phosphate buffer-
8.5 % NaCl-0.3 % formaldehyde (pH 7.2). The same buffer was used to adjust the
suspensions to an optical density at 660 nm of 0.5 to 0.6 when the suspensions were
diluted 1:20. Subsequently, the suspensions were boiled for 60 min at 100° C. After
centrifugation the supernatants were sterilized by filtration through a 0.22-ìm-pore-
size filter and were then used as antigen in agar gel precipitation (AGP) tests as well
as in enzyme-linked immunosorbent assays (ELISAs).
For the AGP test, glass slides were flooded with ± 1 ml of preheated sterile 1.5 %
Noble agar-8.5 % NaCl-0.1 % thimerosal per 5 cm2. Patterns consisting of six or
seven wells (2 mm in diameter) located around a central well at a distance of ± 5 mm
were punched out of the agar. At 1-h intervals the wells were filled twice with ± 15
ìl of undiluted BEAs or serum. The slides were incubated for at least 48 h in a moist
chamber at 37° C and were then observed for precipitation lines under UV light.
For the ELISA, polystyrene microtitre plates were coated with a 1/100 dilution of
BEAs and were incubated overnight at 37°C. The coated plates were incubated for
60 min at 37°C with serial dilutions of the test sera. Subsequently, the bound anti-
bodies were quantified using rabbit anti-chicken Immunoglobulin peroxidase
conjugate (Nordic) and tetramethylbenzidine (Fluka) as the substrate.
RESULTS
Bacteriological identification. Optimal growth of O. rhinotracheale was obtained
when the organism was incubated on 5% sheep blood agar for at least 48 hours under
microaërobic conditions (5 to 10% CO2) at 37° C. Under these circumstances O.
rhinotracheale d veloped small, grey to grey-white colonies, sometimes with a reddish
glow and always with a distinct odor, similar to the odor of butyric acid. Upon primary
isolation, most O. rhinotracheale cultures showed great differences in the colony
size from 1 to 3 mm after 48 h of incubation. When the primary cultures were sub-
cultured, the colony size became more uniform.
The most important biochemical and enzymatic reactions of O. rhinotracheale in
comparison to those of Kingella spp. and the other gram-negative rods related to the
family Pasteurellaceae potentially pathogenic for fowl are listed in Table 1. By using
the same tests and references, O. rhinotracheale can also be differentiated from other
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potential pathogenic gram-negative rods in the families Enterobacteriaceae nd
Neisseriaceae. Within the species O. rhinotracheale, the enzymatic reactions
(performed with API ZYM strips) showed uniform results.
All 443 O. rhinotracheale strains reacted positively in the oxidase test. When
tested in the API 20NE strip at the recommended temperature of 30°C, the p-
nitrophenyl-ß-D-galactopyranoside test (to observe the presence of ß-Galactosidase)
became positive within 3 h for all strains. With the API 20NE strip, 65 % of the
strains also reacted positively in the urease test and four strains (1 %) reacted positively
in the arginine dihydrolase (ADH) test. For all other tests, used in the API 20NE
strip, no reactions were seen even after 72 hours of incubation at 30°C. When strains
were tested at 37°C in the API 20E strip, the urease, ADH and gelatine (for the
presence of protease) tests sometimes reacted positively within 48 hours, even if
they were negative at 30°C by the API 20-NE test.
AGP test. By using BEAs in the AGP test, seven different serotypes (serotypes
A to G) could be distinguished (Table 2 and Fig. 1). Within serotypes A, B, D and E,
different precipitation reactions were seen. The reactions of 88% of the strains
belonging to serotypes A,B,D or E were visualized as sharp precipitation lines. When
BEAs of different strains within a serotype were tested against the corresponding
antiserum the precipitation pattern of the sharp lines showed that the precipitating
antigens were identical. The BEAs of the remaining 12% of the strains produced
faint precipitation lines that also appeared to represent identical precipitating antigens
within each serotype, as indicated by the precipitation pattern found. The BEAs of
eight strains were found to react with more than one antiserum. In addition to a sharp
precipitation line against serotype A or B antiserum with these strains several faint
precipitation lines against serotype A, B or E antiserum were seen. Five strains (1%)
could not be typed by the AGP test with the presently available antisera. All four
strains which reacted positively in the ADH test with the API 20NE identification
strip at 30°C were positive in the AGP test, indicating they do belong to the species
O. rhinotracheale. Information about the geographic origin in relation to the serotype
of 440 O. rhinotracheale strains isolated from chickens and turkeys is listed in the
Tables 3 and 4, respectively.
No reactions were seen in the AGP test between the antigens (BEAs) of the 45
tested O. rhinotracheale strains and the antisera against the Kingella strains or the P.
gallinarum strain. Also, no reactions were seen between the antigens of the 45 tested
O. rhinotracheale strains and all the serotype-specific antisera of 3 Pasteurella-like
rods (P. multocida, R. anatipestifer and H. paragallinarum) known to be pathogenic
for fowl.
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ELISA.  By using the ELISA and monovalent antisera (Table 2), O. rhinotracheale
could be serotyped as described above for the AGP test. Also with use of this ELISA,
O. rhinotracheale could be distinguished from other relevant, gram-negative rods
potentially pathogenic for fowl and with which O. rhinotracheale could be confused.
The monovalent antisera contained large amounts of homologous antibodies (2log
titers up to 22), meaning that background reactions can easily occur. So, with these
sera, we regard ELISA titers up to 10 (2l g) to be a negative reaction, which is an
arbitrary cut-off.  In addition to the data presented in Table 2, antisera against O.
rhinotracheale s rotypes did not react in ELISAs with antigens prepared from the
other species listed. Within each species cross-reactions occurred between the
serotypes, but few cross-reaction between the species were seen. All antisera showed
the highest titer against the homologous antigen. Within the species O. rhinotra-
cheale the cross-reactions were mainly between the serotypes A, B, D and E.
In day-old turkeys as well as day-old broilers, antibodies against O. rhinotracheale
could be detected. Antibody titers between 8 and 12 (2log) were found at that time.
At 3 weeks of age, the same birds were negative in the ELISA (titers, < 5), suggest-
ing that these antibodies were maternally derived. Broiler and turkey flocks from
The Netherlands, Germany, France, the United States, and South Africa presenting
with clinical signs of an O. rhinotracheale infection were investigated for the presence
of antibodies by the ELISA. In all cases, antibodies, especially against serotypes A
and B, could be found (titers, between 8 and 16).
Figure 1. Differentiation of the seven serotypes of O. rhinotracheale (serotypes A to
G) by the AGP test. Capital letters, antigens; lowercase letters, monovalent antiserum.
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Table 3. Serotypes and geographic origin of the isolates of O. rhinotracheale
from chickens.
Country No. of strains of serotype: Total
A B C D E F G NTa
France 3 1 1 1 6
Germany 4 4
Italy 1 1
South-Africa 57 57
The Netherlands 148 6 3 2 159
USA 19 2 21
Total 232 6 2 0 4 0 1 3 248
Percentage 94 2 1 0 2 0 0 1 100
a NT, Not typable with the presently available antisera
Table 4. Serotypes and geographic origin of the isolates of O. rhinotracheale
from turkeys.
Country No. of strains of serotype: Total
A B C D E F G NTa
France 35 8 7 12 62
Germany 1 9 1 11
Israel 2 2
The Netherlands 47 22 9 4 1 1 84
United Kingdom 12 1 13
USA 14 3 3 20
Total 109 44 3 16 17 1 0 2 192
Percentage 57 23 2 8 9 1 0 1 100
a NT, Not typable with the presently available antisera
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DISCUSSION
O. rhinotracheale could be distinguished from other gram-negative rods potential
pathogenic for fowl biochemically as well as serologically. Within the API system
O.rhinotracheale could easily be identified by the API 20NE strip at 30°C. Almost
all strains (99 ) showed an API 20NE code of 0-2-2-0-0-0-4 (65%) or 0-0-2-0-0-0-4
(34%). If the possibility of a positive ADH test is included (code 0-3-2-0-0-0-4 or 0-
1-2-0-0-0-4), a 100% identification score with the API 20NE strip was found. The
enzymes urease, protease, and ADH of O. rhinotracheale showed temperature-depend-
ent reactions in the API 20E and the API 20NE strips.
By the AGP as well as the ELISA, seven serotypes of O. rhin tracheale could be
distinguished. Some cross-reactions were found between the serotypes A, B, D and
E in both tests. In the AGP test it was found that two different precipitating antigens
can occur within the serotypes A, B and E, which probably explains why these sero-
types also show cross reactions in the ELISA. These reactions, as well as the 5
strains (1%) with for O. rhinotracheale positive API 20NE codes which did not
react by the AGP test, need to be investigated more thoroughly.
For identification of O. rhinotracheale, we propose the use of the API 20NE strip
at the recommended temperature of 30°C. Strains with the four possible API 20NE
result codes should be further investigated in the AGP test. We recommend the AGP
test for serotyping, whereas the ELISA might be used for diagnosting infections in
infected birds. For optimal results the antigens or antisera of all seven serotypes
should be used. Therefore we plan to deposit the serotype-specific O. rhinotracheale
strains, as listed in Table 2, in the American Type Culture Collection as reference
strains for general use. The serotype specificity can be seen as a disadvantage for the
use of the ELISA for diagnostic screening purposes because seven tests must be
performed with each serum to exclude an infection. We also found that not all the
birds within an infected flock were serologically positive and that serological res-
ponses in field infections sometimes were low and could disappear after several
weeks. These findings should be kept in mind to prevent incorrect interpretations of
ELISA results. More serological from experimentally and naturally infected birds
are necessary to judge the true value of ELISA for diagnostic purposes. Such studies
are in progress.
As shown in Tables 3 and 4, serotype A was the predominant serotype among the
isolates of O. rhinotracheale from chickens and the most frequently among the isolates
from turkeys. All strains of the serotypes D and F and most strains of serotypes B
(88%) and E (77%) in this study were of turkey origin. It is obvious that in this study
the distribution of isolates of O. rhinotracheale from turkeys among the seven
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serotypes was more heterogeneous than was the case for the isolates from chickens.
Also, relationships between the geographic origins of the strains and the serotypes
seem to exist; e.g. all strains of serotype C originated from California, and all strains
received from South Africa and the United Kingdom (except for one nontypable
strain) belong to serotype A. By testing sera of chicken and turkey flocks suspected
of being infected with O. rhinotracheale by the ELISA, serotypes A and B were
found to react the strongest, which is in agreement with the prevalence of these
serotypes among the isolated strains. However, it should be kept in mind that the
majority of the strains and the sera tested originated from only three areas (France,
The Netherlands and South Africa) which could bias the results. It is not yet possible
to explain the observed differences in distribution of serotypes among isolates of O.
rhinotracheale from chickens and turkeys. Previously, we have shown that a serotype
A strain from a chicken and a serotype B strain from a turkey have similar virulences
for both chickens and turkeys (8). Strains of serotypes C, D and E are also pathogenic
for chickens as well as turkeys (unpublished data). So there is no indication of any
host specificity of the serotypes. A possible explanation may perhaps be found in
different breeding practices in the chicken and turkey industries, but more thorough
epidemiological and pathogenicity studies are needed to obtain final answers to the
remaining questions about the emerging O. h otracheale infection in poultry.
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SUMMARY
Ornithobacterium rhinotracheale is  recently described bacterium associated
with respiratory diseases in fowl. In this study we characterized 56 strains belonging
to different serotypes, independently isolated from bird species from various countries,
by amplified fragment length polymorphism (AFLP), PCR, and polyacrylamide-gel-
electrophoresis (PAGE) of the outer-membrane-proteins (OMP).
With use of the AFLP assay we were able to group O. rhinotracheale strains into
5 minor or 3 major clusters which showed some association with serotyping. Because
the linkage levels between the AFLP banding patterns of these O. rhinotracheale
clusters is comparable to the linkage levels of AFLP banding patterns between
(sub)species of other bacteria, there may be several subspecies of O. rhinotracheale
or even more species of Ornithobacterium. However, this is in contradiction to the
PAGE profiles of the OMP’s of the same 56 strains which show high similarity rates.
Also the fact that the developed PCR proved to be specific for all O. rhin tr cheale
strains tested, indicating that the strains are closely related. Further investigation
will elucidate whether the actual AFLP clustering represent other (sub)species.
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INTRODUCTION
During the period 1991 - 1997, respiratory diseases with mild to moderate symp-
toms in different bird species were observed in several places in the world (4, 5, 9,
12, 13). Bacteriological examination revealed a slowly growing, pleomorphic, gram
negative rod, for which in 1994 the name Or ithobacterium rhinotracheale was
proposed (13). Since the pathogenicity of O. rhinotracheale was proven in
experimental infection (14), a worldwide collection of strains was set up. Up to now
1096 strains of O. rhinotracheale have been investigated biochemically and serologi-
cally. For the biochemical characterization of O. rhinotracheale the API-20NE
identification strip (Bio Merieux, France), incubated at 30°C, was shown to give a
99.5 % identification score in combination with the agar gel precipitation (AGP) test
(15). Serologically, using monovalent antisera in AGP tests, so far nine serotypes of
O. rhinotracheale could be discriminated, designated A - G (15) and H and I (our
own unpublished observation).
To study the bacterium and the epidemiology of this disease, 56 strains of diffe-
rent serotypes were selected. The strains, isolated from different bird species out of
different area’s of the world, were investigated by PCR, DNA fingerprinting and by
outer-membrane-protein analysis.
MATERIALS AND METHODS
Bacterial strains. The geographic origin, the serotype and the origin of the O.
rhinotracheale strains are listed in Table 1. The strains were grown on 5% sheep-
blood agar for at least 48 hours under microaerobic conditions (5-10 % CO2) at 37°
C or in Todd Hewitt (TH) medium (Difco, Detroit, MI, USA) for 24 hours at 37°C.
All strains were identified as O. rhinotracheale with API identification strips and
were serotyped with the agar gel precipitation (AGP) test as described (15).
For comparison, 4 strains of Pasteurella multocida (X-73, P-1059, P-1662 and P-
1702), 3 strains of Riemerella anatipestifer (PAA CV, PAB BRD and PAD CV), 1
strain of Pasteurella gallinarum (fieldstrain), 3 strains of Haemophilus paragallina-
rum (0083, Spross and H-18) and 2 strains of NADH-independent Haemophilus
paragallinarum (281/91 and 4620/91), Kingella kingae (ATCC 23330), Kingella
denitrificans (ATCC 33394) and Kingella (Suttonella) indologenes (ATCC 25869)
were used. These strains were previously used and described when identifying O.
rhinotracheale (15). Vandamme et al. (13) found that based on 16S rRNA sequences,
O. rhinotracheale showed most similarity towards the genus Flavobacterium.
Therefore we also included F. breve (ATCC 14234) and F. meningosepticum (ATCC
13253) in this study.
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PCR. PCR was performed using the primer combination OR16S-F1
(5'-GAGAATTAATTTACGGATTAAG) and OR16S-R1 (5'-TTCGCTTGGTC-
TCCGA-AGAT). This combination amplifies a 784 bp fragment on the 16S rRNA
gene of O. rhinotracheale, and was derived after comparing the sequence of this
gene (Genbank nucleotide sequence accession number L19156) with 16S rRNA  gene
sequences from related species (10). The final PCR volume was 50 µl containing 1µl
of a strength of 1 McFarland suspension of fresh culture in TH medium as template,
2µl dNTP’s (2mM), 4pmol of both primers, 0.5 U Supertaq polymerase (HT-
Biotechology, Cambridge, UK) and 5 µl 10X Supertaq buffer (HT-Biotechnology)
in water. PCR conditions were as follows : denaturation at 94°C for 5 min, followed
by 45 cycles of denaturation at 94°C for 30 sec, annealing at 52°C for 60 sec and
elongation at 72°C for 90 sec followed by a final extension at 72°C for 7 min. Storage
for longer periods was performed at -20°C. PCR products were separated by
electrophoresis in a 1%, ethidium bromide-stained, agarose gel and were visualized
by viewing the gel with an ultraviolet transilluminator.
Amplified fragment length polymorphism (AFLP). DNA was isolated
according to Boom (3), using fresh cells. AFLP was performed essentially as described
by Janssen et al. and Vos et al. (6, 16). Briefly, 50 ng purified chromosomal DNA
was digested with 1 U of Ec RI (Pharmacia Biotech, Uppsala, Sweden) and 1 U of
MseI (New England Biolabs Inc., Beverly,MA, USA). Subsequently, ligation of
adapters to the restriction fragments was performed overnight at 20°C in a final
volume of 30 µl. The ligation mixture consisted of 50 ng of chromosomal DNA, 50
pMol of each EcoRI- and MseI adapter, 1.2 U T4 DNA ligase (Pharmacia Biotech),
1mM ATP and ligase buffer (10mM Tris acetate, pH 7.5, 10mM magnesium acetate,
50 mM dithiothreitol and 50 ng/µl BSA). The structure of the EcoRI adapter is :
5' - C T C G T A G A C T G C G T A C C - 3'
3' - C T G A C G C A T G G T T A A - 5'
The structure of the Ms I adapter is :
5' - G A C G A T G A G T C C T G A G - 3'
3' - C T A C T C A G G A C T C A T - 5'
After ligation the DNA was diluted with water to a final volume of 500 µl and stored
at -20°C until use. The ligated restriction fragments were amplified according to
Koeleman et al. (7) with the fluorescent labeled Eco-A primer (5'-
GACTGCGTACCAATTCA-3') and Mse-C primer (5'-GATGAGTCCTGAGTAA C-
3'), both having an one nucleotide 3'-overhang in the unknown chromosomal DNA.
The final PCR volume was 10 µl containing 0.5 ng template DNA, 20ng Texas Red
labeled Eco-A primer (Isogen Bioscience, Maarssen, The Netherlands), 1µl dNTP’s
(2mM), 60 ng unlabeled Mse-C primer, 1U Taq polymerase (Perkin Elmer) in 10
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mM Tris-HCl (pH 8.3), 50 mM KCl, 1.5 mM MgCl2. Amplification was carried out
in a GeneAmp PCR System 9600 thermal cycler (Perkin Elmer) during 35 cycles:
denaturation (30 sec at 94°C), annealing (30 sec at 65°C-56°C) and extension (60
sec at 72°C). In the first 12 cycles the annealing temperature was lowered 0.7°C per
cycle. After the completion of the cycle program, 3 µl loadingsbuffer (Amersham
Life Science, Cleveland, USA) was added to the reaction mixtures. Prior to gel loading
the amplicons were denatured by heating for 1 min at 95°C and rapidly cooling on
ice. Amplified fragments were separated on a denaturing polyacrylamide gel (6 M
Urea, RapidGel-XL-6%, Amersham Life Science) in 1x TBE buffer (100 mM Tris,
100 mM boric acid, 2 mM EDTA, pH = 8.0) in a Vistra 725 automated DNA sequencer
(Amersham Life Science). Two µl sample of each reaction mixture was loaded on
the gel and gels were run at 1500 V for 6 h.
Clustering analysis of the results of the gelelectrophoresis (saved as TIFF files)
was performed with use of GelCompar 4.0 software (Applied Maths, Kortrijk,
Belgium). The similarity between all possible pairs of traces was expressed by the
Pearson product moment correlation coefficient (r) and grouping was obtained by
the unweighted pair-group clustering algorithm (UPGMA).
Outer membrane proteins (OMP). The OMP’s were prepared according to
Barenkamp et al. (2, 11). Briefly : The cells were suspended in 10 mM HEPES
buffer (pH 7.4) and sonicated 10 times, 30 seconds on ice, using a Branson, model
250 sonifier with standard flat tip at a maximum output with a minimum of aeration.
The cell-debris was removed by centrifugation (25 min; 23,000 g at room temperature).
The supernatant was mixed with 1/4 volume of 5% (w/v) sodium-N-laurylsarcosine
in HEPES buffer and stirred for 2-18 hours at room temperature. Subsequently the
insoluble outer membranes were centrifugated (90 min; 183,000 g at room
temperature) and the pellet was resuspended in a minimal volume of HEPES buffer
with 0,1% sodium azide and stirred until the suspension was completely homogene-
ous. The OMP’s were separated through sodium dodecyl sulphate (SDS)-polyacryla-
mide-gel-electrophoresis (PAGE) according to Laemmli (7), using a 12% T-gel and
a 2.6% C-gel. The interpolation of the protein profiles was performed by using the
model GS-700 imaging densitometer and the algorithm of Ward in the Molecular
analyst software package (Bio-Rad, Hercules, CA, USA).
RESULTS
PCR. A 784 bp amplicon was observed in the PCR with all the 56, API-20NE
and AGP confirmed, O. rhinotracheale strains. None of the tested strains of the
species P. multocida, R. anatipestifer, H. paragallinarum, NADH-independent H.
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paragallinarum, P. gallinarum, K. kingae, K. denitrificans, K. indologenes, F. breve
and F. meningosepticum a plified the 784 kb amplicon product. In the collection of
1096 O. rhinotracheale strains, 6 strains were found to react biochemically but not
serologically as O. rhinotracheale. These 6 strains did react as O. rhinotracheale in
the PCR and are currently under investigation to identify possible new serotypes.
The sensitivity limit of the PCR was between 180 and 4500 bacteria. It was found to
be critical to use fresh cultures for PCR. If cultures were allowed to grow for longer
than 48 hours, the PCR failed in most cases.
AFLP.  Using a similarity coefficient (Sd) of 70% as a distinctive linkage level, 5
different clusters of O. rhinotracheale strains could be discriminated (Figure 1 and Table
1). The clusters 1 and 2 showed an Sd of 67%, cluster 3 showed an Sd of 51% with
clusters 1 and 2, cluster 4 showed an Sd of 46% with the clusters 1, 2 and 3 and cluster 5
showed an Sd of 28% with the other clusters. In cluster 1 we found 9 out of the 10 tested
serotype A strains, 6 out of 10 serotype B strains, 4 out of 5 serotype C strains, 7 out of 10
serotype E strains, 1 out of 3 serotype F strains and 1 out of the 3 tested serotype H
strains. In cluster 2 we found 1 out of the 10 tested serotype A strains, 4 out of 10
serotype B strains, 1 out of 10 serotype E strains and 1 out of 2 serotype G strains. The
serotype-C-strain ORV K91-201 (strain no. 21) was the only strain that was placed in
cluster III. All the serotypes D and I strains were placed in cluster IV together with 2 out
of 10 serotype E strains, 1 out of 3 serotype F strains, 1 out of 2 serotype G strains and 2
out of the 3 tested serotype H strains. Cluster IV contained only strains isolated from
turkeys. One strain, serotype-F-strain ORV 94084 K858 ORT (strain no 46), showed a
totally different profile and was placed in cluster V.
If an Sd of 50% was used as distinctive linkage level 3 clusters (a,ß and g ) could
be distinguished. Cluster a contained the clusters I, II and III, in which all of the
serotype A, B and C strains were placed. The clusters ß and g were identical to the
clusters IV and V respectivily.
OMP. Using a Sd of 90% as a distinctive linkage level, 5 different OMP-profile
clusters could be discriminated (Figure 2 and Table 1). The lowest Sd was found to
be 84%, comparing the clusters 1, and 2 with the clusters 3, 4 and 5. Clusters 1 and
2 had an Sd of 85%, cluster 3 had an Sd of 87% with the clusters 4 and 5 and cluster
4 had an Sd of 89% with cluster 5. No correlations could be found between the OMP
clusters and AFLP, serotyping, bird species and origin.
DISCUSSION
All strains that tested biochemically and serologically as O. rhinotracheale, were
identified as such by AGP or the PCR. The PCR was found to be specific and thus
useful for identification purposes. The primer combination OR16S-F1 and OR16S-
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R1 amplifies a 784 bp fragment of the rnn gene of O. rhinotracheale but not of other
bacteria with which O. rhinotracheale may be confused. This PCR should also be
suitable for the demonstration of O. rhinotracheale in e.g. eggs, faeces, dust- or
tissue samples. But the sensitivity of the assay needs to be improved.
The results of the AFLP indicate that, within the species O. rhinotracheale,
subgroups do exist. The choice of the primer-set affects the number of fragments in
the AFLP banding patterns and therefore is of importance for the interpretation of
similarities, Janssen et al. found that a decrease in the number of bands resulted in
significantly lower linkage levels between clusters (6). The primer-set we used,
produced between 18 and 28 bands in the AFLP banding pattern of O. rhinot acheale
strains. Janssen t al. (6) found that for the genera Xanthomonas nd Aeromonas,
using between 15 and 25 bands in the AFLP banding patterns, species could be
distinguished at Sd-values of about 60% and 64% respectivily. In the same study
most of the subspecies of Xanthomonas axonopodis and Xanthomonas vasicula ould
be distinguished at Sd-levels higher than 70%. Although we do not know anything
about the differences between these genera and Or ithobacterium with regard to e.g.
the ability to exchange genetic material, we propose the arbitrary Sd-values of 70%
and 50% as levels at which subspecies and species should be separated, respectivily.
Based on this assumption O. rhinotracheale should be divided into at least 5 sub-
species (I to V) or even that the genus Ornithobacterium should be divided into 3
“species” a, ß and g, of which a can be divided into 3 subspecies). However, we did
not find other arguments in this study that convincingly could confirm the division
of Ornithobacterium into 3 species. Although all serotype A, B and C strains were
found in “species” a including the AFLP clusters I, II and III, and all serotype D
strains were found in “species” ß, several other serotypes were found to be represented
in both these “species” (Table 1). Furthermore, the 3 serotype F strains than would
belong to the 3 different “species”.
Except for the studies by Amonsin et al. (1) and Vandamme et al. (13), no other
genetic studies of O. rhinotracheale have been reported. Amonsin et al. found 6
different rep-PCR types of O. rhinotracheale, with only minor differences, together
with >99% 16S rRNA sequence-identity among the tested strains. Vandamme et al.
investigated the 16S rRNA sequence, DNA-DNA binding values and G+C contents;
they found high similarity between strains. Only 2 strains used in both studies, B3263/
91 (AFLP cluster I, serotype A) and GGD-1261 (AFLP cluster I, serotype B), were
included in our study, so no comparison between the studies can be made. In
conclusion, we believe that the clusters of O. rhinotracheale strains, found with the
genomic fingerprinting AFLP-assay, might be regarded as (sub)species, but more
research is needed before changes should be proposed in the current nomenclature.
The OMP profiles showed high similarity levels (Sd > 84%) similar to the data
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a Strain no 34 was at the beginning of these studies misinterpreted as serotype D.
b Number as used in the tests.
c AFLP cluster as determined with an Sd of 70% as distinctive linkage level.
d OMP cluster as determined with an Sd of 90% as distinctive linkage level.
e Not tested
Footnote table 1:
from Vandamme et al. (13) with total protein profiles (Sd > 89%). Using an Sd of
90% as an arbitrary distinctive level, no correlation of OMP profiles with either the
serotyping or AFLP profile as tested in this study was found. These data do not
support the idea that (sub)species of O. rhinotracheale do exist. However, the Sd-
levels of the total-protein profiles of the 5 species of the genus Capnocytophaga,
found to be closely related to O. rhinotracheale, showed the same narrow range of
Sd-levels of the total-protein profiles (13) and the OMP-profiles of O. rhinotracheale
(this study).
In conclusion, the high similarity of OMP profiles among the tested O.
rhinotracheale strains without any correlation with the different serotypes found,
suggesting that the tested isolates, originating from all over the world and from several
bird-species, are represented by a small group of closely related clones. But the
AFLP results in this study suggest a larger distance between subspecies of O.
rhinotracheale or even species of Ornithobacterium. This should be investigated
more thoroughly e.g. by looking at markers covering the whole genomen.
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Table 1: Designations, sources and test results of Ornithobacterium rhinotracheale
strains used, listed according to serotypea.
No.b Strain Bird speciesOrigin Year of isolationSerotypeAFLPc OMPd
1 B 3263/91 Chicken South Africa 1991 A I 1
2 O-96218 GEE 5 Turkey The Netherlands 1996 A I 1
3 O-96214 SP 4542 Chicken The Netherlands 1996 A I 1
4 O-96148 BAC.96.0108 Chicken USA, Virginia 1996 A I NTe
5 O-96069 BAC.960043 Chicken USA Delaware 1996 A NT 2
6 O-96100 1530 Turkey France 1996 A I 2
7 O-95264 95.2932 Guinee fowlFrance 1996 A I 2
8 OND.NR.2141(5) EXP 2030Chicken South Africa 1990 A I 3
9 ORV PAST.HONG 87121 Duck Hungary 1987 A I 1
10 ORV 94080 STRAIN 5 Chicken Italy 1994 A I 1
11 GGD 1261 Turkey Germany 1991 B I 2
12 O-96177 SP 426 TRA 1 Turkey The Netherlands 1996 B I 1
13 O-96121 SP 254 PE 1 Turkey The Netherlands 1996 B I 3
14 O-96148 BAC.96.0107 Chicken USA, Virginia 1996 B I 3
15 ORV 448 GELATINE 95-0134Turkey USA West Verginia1995 B I 2
16 O-96111 DDX 125 Turkey France 1996 B II 2
17 O-95159 7442 TR Turkey France 1995 B II 1
18 ORV 94099 NR:1648 Turkey Germany 1994 B I 1
19 ORV 94099 NR:2009 Turkey Israel 1994 B II NT
20 ORV 94099 NR:2010 Turkey Israel 1994 B II NT
21 ORV K91-201 Chicken USA California 1991 C III 1
22 O.R K90-118 Turkey USA California 1990 C I NT
23 O.R K89-1234 Turkey USA California 1989 C I 1
24 O.R.K90-1455 Turkey USA California 1990 C I 1
25 O.R K91-524 Chicken USA California 1991 C I 1
26 ORV 94108 nr.2 Turkey France 1994 D IV 1
27 O-96156 SP 401 OOG Turkey The Netherlands 1996 D IV NT
28 ORV 94081 494 Turkey The Netherlands 1994 D IV 3
29 O-95156 SP 401 LZ Turkey The Netherlands 1995 D IV 3
30 O-095156 SP 401 TRA 4 Turkey The Netherlands 1995 D IV 1
31 O-095156 SP 401 TRA 5 Turkey The Netherlands 1995 D IV 1
32 O-96100 SP 3471 Turkey France 1996 D IV 3
33 O-95231 95-2498 Turkey France 1995 D IV 1
34 O-96051 60201 Turkey France 1996 A II 4
35 O-95246 25791 Turkey France 1995 D IV 1
36 0-95029 NR. 12229 Chicken France 1995 E II 1
37 ORV 94067 14200-283 Chicken The Netherlands 1994 E I 4
38 ORV 94077 SP 758 COR Turkey The Netherlands 1994 E IV 5
39 O-96117 SP 254 Turkey The Netherlands 1996 E I 2
40 O-96117 SP 198 Turkey The Netherlands 1996 E I 4
41 O-95069 SL-95-105NR.1 Turkey France 1995 E I 5
42 O-95029 NR. 13778 Partridge France 1995 E I 4
43 O-95246 52787-6 Turkey France 1995 E I 4
44 ORV 94087 SL-94-141 NR.1Turkey France 1994 E I 5
45 O-93075 Turkey Germany 1993 E IV 5
46 ORV 94084 K858 ORT Turkey The Netherlands 1994 F V 5
47 O-96222 SP 704 LONG 1 Turkey The Netherlands 1996 F IV 5
48 O-96222 SP 704 LONG 2 Turkey The Netherlands 1996 F I 1
49 O-95029 NR. 16279 Chicken France 1995 G II 1
50 O-94038 K334 Turkey The Netherlands 1994 G IV 1
51 E-94063 4.2 Turkey The Netherlands 1994 H IV 1
52 O-97041 VRE 9 Turkey The Netherlands 1997 H IV 1
53 O-97041 EVE 9 Turkey The Netherlands 1997 H NT 1
54 O-97071 BUT 2266/3 Turkey United Kingdom 1997 H I 1
55 O-95265 sp 1071 Turkey The Netherlands 1996 H NT 3
56 BAC 96-0334 #MINN 18 Turkey USA Minnesota 1996 I IV 1
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Figure 1: Digitized AFLP patterns obtained from DNA of 53 O. rhinotracheale
strains. Clusters I - V were separated by using an Sd of 70% as a distinctive linkage
level. Clusters a, ß and g were separated by using an Sd of 50% as a distinctive linkage
level. bp = base pairs. Numbers correspond with the strain numbers listed in Table 1.
47
Chapter 3
Figure 2: SDS-PAGE patterns obtained from OMP’s of 51 O. rhinotracheale
strains. Clusters 1 - 5 were separated by using an Sd of 90% as a distinctive linkage
level. Numbers correspond with the strain numbers listed in Table 1.
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SUMMARY
Ornithobacterium rhinotracheale, the causitive agent of a respiratory disease in
poultry, was cultivated from egg-shells and from yolk sacs of one day old birds.
Treatment of broiler chickens and turkeys, apparently carrying the bacterium, with
known triggering respiratory viruses induced the the same kind of lesions in the air
sacs of birds as elicited by O. rhinotracheale in experimental infection experiments.
From these affected air sacs O. rhinotracheale was isolated. These experiments were
carried out on conventionally kept animals. Additional experiments were carried out
in which animals were housed under conditions used for specific pathogen free ani-
mals. Broiler chickens and turkeys hatched from breeder flocks with a known O.
rhinotracheale history were used. O. rhinotracheale also was cultivated from inflamed
air sacs after an infection with Newcastle disease or turkey rhinotracheitis virus. In
conclusion, evidence was found that O. r inotracheale can be transmitted by eggs.
To determine whether cloacal vertical transmission occurs, additional experiments
would be requested.
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INTRODUCTION
Ornithobacterium rhinotracheale as been shown to be the causative agent of a
respiratory disease in poultry with clinical signs such as weakness, gasping, severe
dyspnoea and mucus discharge. Dissection of diseased birds showed fibrinopurulent
pneumonia and fibrinous inflammation of the air sacs (1, 5, 6, 7). It was proven that
various respiratory viruses, such as turkey rhinotracheitis virus (TRT) and Newcastle
disease virus (ND), have a triggering effect on the outcome of O. rhinotracheale
infections (3).
Up to now the infection route of O. rhinotracheale is not known. The occurrence
of O. rhinotracheale infections in various countries at an early age of the birds (1, 7),
and the finding that maternally derived antibodies can be found in broiler and turkey
flocks (4) indicates that the breeders of these flocks are in contact with O. rhinotra-
cheale and that transmission by eggs may occur.
In this study we present the results of challenge tests in turkeys, using TRT virus
as trigger, and in broiler chickens, using ND virus as trigger. In these tests we
repeatedly found that eggs transmitted O. rhinotracheale. To investigate this
transmission further, tests under specific pathogen free (SPF) conditions were carried
out in broiler chickens and turkeys, using the same viral triggers. During these tests
we also investigated whether O. rhinotracheale could be cultivated from eggs and
from yolk-sacs of one-day-old birds.
MATERIALS AND METHODS
Isolation of bacteria. For isolation of O. rhinotracheale swabs from egg-yolk,
yolk sacs or affected organs (air sacs, lungs and tracheae) were taken and inoculated
onto sheep blood agar. Samples of eggshells, egg-white and egg membranes from
infertile eggs, as well as the remainders of the eggs and samples from yolk sacs of
one-day-old birds, were inoculated into 10 ml of brain heart infusion (BHI) broth,
incubated for 3 days at 37°C and subcultured on sheep blood agar and on sheep
blood agar with 5 µg/ml gentamicin and 5 µg/ml polymyxin (to inhibit growth of
other bacteria). The agar plates were incubated at 37°C in a atmosphere containing
5-10% CO2  for at least 3 days. Each day the agar plates were checked for suspected
colonies (small, grey and not haemolytic). Such colonies were subcultured under the
same conditions.
Identification of bacterial isolates. Bacterial isolates were identified using the
API identification system (BioMérieux, La Balme les Grottes, France).
O. rhinotracheale, which is not included in the API system, was identified with the
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API-20NE identification strip and the agar gel precipitation (AGP) test as previously
described (4). Briefly, boiled extract antigens of oxidase positive, gram negative rods
with an API-20NE code 0-2-2-0-0-0-4 or 0-0-2-0-0-0-4 were tested in an AGP, using
monovalent anti-sera against the seven known serotypes of O. rhinotracheale (4).
Animals and eggs. In preliminary tests, fattening turkeys were commercial British
United Turkeys (Plukon, Ruinen, The Netherlands) and chickens were commercial
Hybro-broilers (Interbroed, Gemert, The Netherlands). Both turkeys and chickens
were purchased as 18 to 20 days embryonated eggs and housed in isolators
immediately after hatching. Food (Hendrix’ voeders, Heijen, The Netherlands) and
water were given ad libitum.
In the experiments under SPF conditions the same breeds of birds were used. The
eggs were purchased from breeder flocks with a known O. rhi otracheale history
and with ELISA antibodies against O. rhinotracheale. Embryonated eggs were cleaned
with a dry cloth but not dipped in a desinfectant or antibiotic. The eggs were
transported immediately after lay to separated, thoroughly cleaned and previously
formalinized incubators. Immediately after hatching, the birds were transported in
closed, sterile sacs to sterilized isolators. Food, sterilized by g-radiation (GS 4700,
Hope Farms, Woerden, The Netherlands), and heat sterilized water were given ad
libitum. The 36 turkey eggs and 65 chicken eggs, used for direct cultivation, as well
as the 40 one-day-old turkeys and 50 one-day-old broiler-chickens, used for yolk-sac
cultivation, were purchased from breeder flocks with a known O. rhi tracheale
history.
Virus infection. Virus infection was performed as described (3). A culture of
TRT virus strain 3B OC21 was administered to 25 turkeys by eye drop and nose drop
containing at least 106.6 median ciliostatic doses per bird, at 8 days of age in the
initial test. In the test under “SPF” conditions, TRT was administered at 7 days of
age to 25 turkeys.
A lentogenic ND virus strain LaSota was administered to two groups of broiler
chickens (group A contained 20 and group B contained 24 birds), at an age of 21
days, by spray containing at least 106 median egg infectious doses per bird. In the
initial tests virus was administered to the birds at 21 days of age and in the “SPF
test” at 7 (23 birds) or at 21 (24 birds) days of age.
Post mortem investigation. In the initial tests, post mortem examinations were
performed on turkeys 12 days post TRT administration and on chickens 12 and 19
days post ND administration. The birds in the “SPF tests” were examined 10 days
post TRT administration and 9 days post ND administration. The macroscopical
lesions were recorded as described previously (3) and affected organs were cultured
for O. rhinotracheale.
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Serological investigation. Serum and yolk-sac samples were tested in an enzyme
linked immunosorbent assay (ELISA) against boiled extract antigens of seven strains
of O. rhinotracheale with different serotypes as described previously (4).
RESULTS
TRT administration to turkeys. Twelve days after TRT administration, at 20
days of age, 2 out of 25 turkeys showed severe airsacculitis. This group of turkeys
was meant as a TRT-control group in a challenge experiment with O. rhi otracheale
and was supposed to be kept free of O. rhinotracheale. Still from the abdominal air
sacs of one turkey an almost pure culture of O. rhin tracheale could be isolated. In
the negative control group of this challenge experiment, which did not recieve TRT,
no airsacculitis was found.
ND administration to chickens. I  2 separate experiments, ND strain LaSota
was given to a group of chickens (groups A and B). One chicken out of group A died
7 days post ND administration. This bird, and 3 further birds of this group showed
severe airsacculitis at post mortem investigation 12 days post ND administration.
From the air sacs of 2 of these birds O. rhinotracheale was isolated. The remaining
16 birds out of group A showed no or minor airsacculitis.
The 10 chickens from group B, examined 12 days post ND administration, all
showed severe airsacculitis, mostly in the abdominal air sacs (typical for an O.
rhinotracheale infection) with a total group score of 50% of the maximal possible
score. The remaining 14 animals were examined 19 days post ND administration
and 13 of them showed severe airsacculitis with a total group score of 54 % of the
maximal possible score. O. rhinotracheale could be isolated from the affected air
sacs of 14 of the 23 chickens of group B that showed airsacculitis.
Both groups of chickens served as a ND control group in challenge experiments
with O. rhinotracheale. They were housed in isolators and supposed to be kept free
of O. rhinotracheale. In the negative control groups of these challenge experiments,
which did not receive ND, no airsacculitis was found and O. rhinotracheale could
not be isolated.
Tests on animals housed under SPF conditions. In these tests, the chickens
which were given ND at 7 days of age, all showed an inflammation of the thoracic
air sacs but not of the abdominal air sacs at 9 days post ND administration. E. coli,
Aerococcus viridans and Enterobacter cloacae but no O. rhinotracheale could be
cultured from the affected air sacs. Also all chickens, which were treated with ND at
21 days of age, showed airsacculitis in the thoracic but hardly any in the abdominal
air sacs 9 days post ND administration. From the thoracic air sacs of 1 and the abdomi-
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nal air sacs of 2 of these birds, O. rhinotracheale could be isolated. From the air sacs
of all birds E. coli and Aerococcus viridans d of some birds Staphylococcus aureus
could be cultured.
In the conditioned test in turkeys, 21 of the 25 turkeys which were given TRT at
7 days of age, showed inflammation of the thoracic air sacs and 4 turkeys showed
minor inflammation of the abdominal air sacs 10 days post TRT administration. E.
coli, Aerococcus viridans d Proteus mirabilis could be cultured from all the affected
air sacs. From the thoracic air sacs of one turkey and the abdominal airsacs of another
bird, O. rhinotracheale could be isolated.
Cultivation of eggs and yolk sac material. From the inner surface of the shell of
only one chicken egg (out of the in total 101 eggs sampled) O. rhinotracheale could
be isolated. All other samples remained negative. The remainders of the eggs and
swabs from yolk-sacs of 40 one-day-old turkeys were investigated for the presence
of O. rhinotracheale. All samples were overgrown by E. coliand/or Enterobacter
cloacae. Even after subculturing, these samples remained negative for O. rhinotrache-
ale. The remainders of the eggs and swabs from yolk-sacs of 50, one-day-old broiler
chickens were also investigated for the presence of O. rhinotracheale. In most samples
E. coli and/or Enterobacter cloacae was found. But from 2 yolk-sac samples O.
rhinotracheale could be cultured.
ELISA.  When serological responses against O. rhinotracheale were found, they
were predominantly against serotype A. In all turkeys and chicken sera antibodies
against O. rhinotracheale were found at one day of age. The antibody levels in the
yolk-sacs at one day of age were similar to those in the sera (2log titres between 7 and
12). No antibodies were found at 14 days of age anymore (titre £ 4).
When measured 12 days post ND administration, 5 of 10 chickens out group B
showed weak serological reactions against O. rhinotracheale (titres between 5 and
8). At 19 days post ND administration 5 of 14 chickens out of group B showed
slightly increased serum titres against O. rhinotracheale (titres between 8 and 12).
The negative control group (no ND administration) remained serologically negative
against O. rhinotracheale.
In the “SPF tests”, at one day of age, the chickens as well as the turkeys had
serum antibodies against O. rhinotracheale (titres between 8 and 11). At 7 and 21
days of age, when viruses were administered, all serum samples were negative (titres
£ 4). Nine days post ND administration and 10 days post TRT administration, weak
serological reactions against O. rhinotracheale were seen for 10 of the 47 chickens
and 7 of the 25 turkeys (titres between 5 and 9). Birds not treated with viruses remained
serologically negative.
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DISCUSSION
In 3 separate challenge tests, one using turkeys and two using chickens, it was
found that birds, that were supposed to be kept free of O. rhinotracheale, showed
airsacculitis after administration of the respiratory viruses which can be used as
trigger for O. rhinotracheale infections. The airsacculitis was similar to that
encountered in challenge tests with O. rhinotracheale (3) and from the affected air
sacs O. rhinotracheale could be isolated. So the probable cause of the airsacculitis
was an infection with O. rhinotracheale. In the control groups of these tests, which
did not receive respiratory viruses, no airsacculitis was found and O. rhinotr cheale
could not be isolated. Because the animals used in these tests were purchased as
embryonated, commercial eggs and placed in separated, clean isolaters immediately
after hatching, there is hardly any chance that the O. r inotracheale infections were
caused by contact, unless the incubator, food or water was contaminated with O.
rhinotracheale. This indicated that O. rhinotracheale might have been transmitted
through the eggs.
To exclude any external contaminations, the broiler chickens and turkeys in the
next tests were purchased immediately after lay and then hatched and housed under
SPF conditions. Also sterile food and water was given. Knowing that it is very difficult
to cultivate O. rhinotracheale from diseased birds, even in experimentally infected
birds (4), it is important to use highly susceptible birds. So to make the birds more
susceptible for the triggering viruses and by this way giving an O. rhinotr cheale
infection a good chance to develop, the birds did not receive any vaccinations prior
to the ND or TRT administration. As a result of the virus administrations, almost all
birds showed airsacculitis in the thoracic air sacs probably caused by the virus
administration as reported before (2, 3). From affected air sacs O. rhinotracheale
together with bacteria commonly found on eggs, like E. coli Enterobacter cloacae,
Aerococcus viridans or Staphylococcus aureus, could be isolated. The incidence of
the O. rhinotracheale isolations was low, which is in agreement with the findings in
the field (1, 3, 7). The isolation of O. rhinotracheale from air sacs in these tests
proves that O. rhinotracheale infections in broilers can be caused by the presence of
the bacterium in the breeder flock. We also found that treatment of birds with
respiratory viruses evoked weak antibody reactions against O. rhinotracheale while
untreated birds remained negative. O. rhinotracheale could be isolated from yolk-
sacs of one-day-old birds and from the the eggshell but not the inner parts of the egg.
These results provide evidence that some kind of vertical transmission of O.
rhinotracheale from infected breeders to progeny takes place. This is of importance
to control the disease by hygienic measures or vaccination. Whether cloacal or ovarial
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transmission is involved still remains to be established.
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SUMMARY
With use of an immuno-histochemical technique, Ornithobacterium rhinotracheale
was proven to be the causitive agent of lesions in the air sacs and lungs in chickens,
but only when O. rhinotracheale was exposed to the bird after priming with Newcastle
Disease (ND) virus. At first the bacteria attached to the epithelium of the air sacs,
lateron they infiltrated the air sacs and caused thickening, the formation of oedematous
and granulomatous tissue and a strong accumulation of macrophages. The infection
peaked at 5 to 9 days post O. rhinotracheale exposure after which recovery was
seen. In the lungs some areas with bronchial associated lymphoid tissue were affected.
Further no other organs were proven to be affected.
 Without ND priming, aerosol exposure of O. rhinotracheale to chickens only
resulted into minimal and temporary microscopic air sac lesions. No O. rhinotracheale
cells or fragments could be detected at any time point later than 2 days post exposure.
However, without showing visible lesions, chickens exposed to O. rhinotracheale
without ND priming reacted serologically equally as compared to chickens exposed
after ND priming, with the same duration and strength of response.
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INTRODUCTION
Ornithobacterium rhinotracheale as been repeatedly found to be involved in
cases of respiratory diseases in broiler-chickens and meat turkeys (1, 3, 4, 5, 6, 7, 9,
10, 11,  12). Clinically, relatively mild respiratory symptoms were accompanied by
increased mortality and growth retardation. Post mortem investigations showed a
foamy, yellow-white, “yogurt like” exudate in the air sacs, predominantly in the
abdominal air sacs and sometimes accompanied with a purulent pneumonia, often
unilateral, and/or exsudate in the trachea. Experimental infection demonstrated that
aerosol exposure with an O. rhinotracheale culture was only capable of reproducing
the clinical features of the disease, if the birds were primed previously by the
administration of respiratory viruses (13).
In this study, bacteriological, serological and immuno-histochemical examinations
were performed to study the course of disease after experimental infection of chickens.
MATERIALS AND METHODS
Animals. Chickens were SPF leghorns (Intervet, Boxmeer, The Netherlands).
All animals were placed in isolaters at one day of age. The birds did not receive any
vaccination or treatment and only sterilized food and water was given ad libitum.
Challenge. The first group, containing 30 birds, was infected at an age of 26 days
as previously described (13), using an aerosol, made of 100 ml of a culture of O.
rhinotracheale strain B3263/91 (serotype A) containing 3.8 x 108 CFU per ml. The
birds were infected 5 days post administration of a spray of Newcastle Disease (ND)
virus strain LaSota as viral primer. The second group of 30 birds was treated with an
aerosol of the same culture of O. rhinotracheale strain B3263/91 at 26 days of age,
but without the ND priming. The third group of 30 birds received a spray of ND
strain LaSota at 21 days of age but no O. rhi tracheale exposure. The fourth group
of 30 birds was kept as a negative control group.
Serology. Bloodsamples were taken every week up to 14 weeks post O. rhinotra-
cheale exposure and at post-mortem investigation. Antibodies against O.
rhinotracheale s rotype A were quantified with use of an enzyme linked immuno-
sorbent assay (ELISA) as previously described (14).
Post-mortem examination. Post-mortem examination was performed at 1, 2, 3,
4, 5, 7, 13 and 15 days after O. rhinotracheale exposure on 2 birds of each group and
on the remaining birds 14 weeks after exposure. The birds were bled, lesions were
scored as described (13) and samples for histological investigation were taken from
the thoracic airsacs, abdominal airsacs, lung, trachea, brains, pericardium, heart,
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duodenum, pancreas, spleen, liver, proventriculus, gizzard, bursa, thymus, skin of
the head and flexor tendons of the hock. Samples were fixed in 10 % neutral buffered
formalin, routinely processed to paraffin sections and stained with haematoxylin
and eosin.
Bacteriology. During autopsy, the air sacs, lungs, trachea and any abnormal organs
were sampled with cotton swabs for isolation of O. rhi tracheale. The swabs were
inoculated on sheepblood agars and on sheepblood agars + polymyxin + gentamicin
(both 5 µg per ml, used to suppress growth of other bacteria). The agars were incubated
at 37°C under 5 - 10 % CO2 atmosphere for 72 hours. Colonies, suspected to be O.
rhinotracheale, were subcultured and identified with use of a Gram-stain, API-20NE
identification strips and agargel precipitation (AGP) test as previously described
(14).
Peroxidase anti peroxidase (PAP) staining. PAP tests were performed on paraffin
sections. The primary antiserum against O. rhinotracheale, used in the PAP method,
was a monovalent rabbit antiserum against strain B3263/91 (serotype A). The serum
was prepared by injecting SPF New Zealand white rabbits (van Broekhoven, Som-
eren, The Netherlands) with a bacterin in oil-adjuvant twice with 3 weeks interval.
Serum was collected 4 weeks after the second injection.
The PAP method was performed as described by Bourne (1983). Briefly, sections
were treated with H2O2 to remove endogeneous peroxidase activity, then blocked
with swine serum and incubated with the monovalent rabbit antiserum against O.
rhinotracheale. Subsequently, the sections were incubated with a linking swine-anti-
rabbit serum. After washing they were incubated with a horseradish peroxidase-
rabbit-antiperoxidase complex (Dako, Santa Barbara, USA) and treated with diamin-
obenzidin as substrate. Finally the slides were counterstained with haematoxylin.
(8) and examined microscopically (magnifications 200 x and 600 x).
RESULTS
Serology. The serological responses after challenge are visualized in Figure 1.
Responses were detectable at 5 days and peaked at 7 days post O. rhinotracheale
exposure with individual 2log titres from 9 up to 16. No differences were found
between chickens exposed to O. rhinotracheale after ND priming and chickens
exposed to O. rhinotracheale  without ND priming. Hardly any decrease in antibody
titres was observed within the 100 days observation period.
Bacteriology. During the first 10 days post exposure, O. rhinotracheale could be
isolated from 34% of the samples taken from the air sacs and the lungs of birds
exposed to O. rhinotracheale after ND priming. From the trachea samples O. rhino-
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tracheale could only be isolated during the first two days post challenge. O. rhino-
tracheale could not be isolated anymore at time points later than 10 days post chal-
lenge.
Figure 1. Average serological response against O. rhinotracheale s rotype A. ND
virus was administered at 21 days of age and O. rhinotracheale was exposed at 26
days of age. o = ND + O. rhinotracheale; n = O. rhinotracheale only;  = ND only;
l = Control.
After exposure of chickens to O. rhinotracheale without ND priming, isolation
of O. rhinotracheale was possible out of 18% of the air sacs and trachea samples,
only during the first two days post exposure.
Post-mortem investigation. Airsacculitis was found in the chickens exposed to
ND alone or ND and O. rhinotracheale. The airsacculitis in the group chickens
exposed to ND alone scored between 0% and 20% of the maximal possible score
while the airsacculitis in the group chickens exposed to ND and O. rhinotracheale
scored between 60 and 100% with the strongest reaction at 5 - 7 days post O.
rhinotracheale xposure. Pneumonia was found in chickens exposed to O.
rhinotracheale after ND priming only. Tracheitis was found in 10 - 20 % of both
groups of chickens treated with ND but only at the beginning of the experiment.
Histology. Throughout the test no consistent abnormalities were detected micro-
scopically in the heart, pericard, cerebrum, cerebellum, brain stem, thymus, nose,
eyelid, head-skin, kidney, spleen, bursa, ceacum, ileum, duodenum, pancreas,
proventriculus, gizzard or flexor tendons at the hock.
In the control-group, no consistent abnormalities were detected. In the group that
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was treated with ND alone, moderate to severe tracheitis with epithelial hyperplasia
and lymphocytic infiltration in the epithelium and lamina propria, as well as mini-
mal airsacculitis, characterised by mononuclear inflammatory cell infiltration and
lymphoid follicular hyperplasia of the air sacs, were found up to 10 days post ND
treatment.
In the group that was treated with O. rhinotracheale alone minimal infiltration of
the air sacs by polymorphonuclear granulocytes (PMN) was seen at one day post
exposure. Immuno-histochemistry of these air sacs could demonstrate bacteria on
the epithelial surface of the air sac at the site of inflammation. Mild infiltration of the
epithelium of the respiratory side by PMN's was found and O. rhinotracheale bacteria
or bacterial fragments were attached to the cilia of the epithelium (Figure 2). Immuno-
histochemistry could not demonstrate any O. rhi otracheale bacteria or bacterial
fragments at time points later than one day post O. rhin tracheale exposure in the
group treated with O. rhinotracheale alone.
In the group exposed to O. rhinotracheale after ND treatment, several lesions,
related to O. rhinotracheale, could be seen in the air sacs, the lungs and to a lesser
extent in the trachea. One day post O. rhinotracheale exposure the reactions were
similar to the reactions seen in the group that was exposed to O. rhinotracheale
alone. Two days post exposure several O. rhinotracheale c lls were seen, attached to
the epithelium of the thoracal air sacs, especially at the cuboidal epithelium at the
site of transition of the air sacs to the lungs (Figure 3). Infiltration of the air sac
epithelium and lamina propria by accumulation of macrophages and PMN’s was
seen with presence of cell debris and inflammatory cells in the air sac lumen (Figure
4). The air sacs were thickened, oedema was present and acute granulomatous
airsacculitis related to the presence of O. rhinotracheale antigen, as demonstrated
by immunohistochemistry (Figure 5), was developing. Four and five days post
exposure, the air sacs were clearly thickened and O. rhinotracheale c lls or fragments
were abundantly found in the epithelium, in the lamina propria and on the surface of
the air sacs in the lumen. Most of the positive staining in immunohistochemistry was
associated with single and accumulated macrophages (figure 6). At 5 days post
exposure, infiltration and necrosis of the bronchial associated lymphoid tissue (BALT)
was seen in some areas of the lungs (Figure 7) while other parts of the same lung
were not affected at all. Within the affected BALT-areas strong staining was found
for O. rhinotracheale by immuno-histochemistry (Figure 8). No staining for O.
rhinotracheale c lls or fragments could be detected in any tissue other than lungs or
air sacs. Air sac lesions were still present at 13 days post exposure in the group
exposed to O. rhinotracheale after ND treatment. At that time point they consisted
of multifocal hyperplasia of the epithelium with thickening of the air sac wall and
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infiltration of the lamina propria by mononuclear inflammatory cell accumulations
and few granulomas. Immuno-histochemistry could demonstrate O. rhi otr cheale
cells or fragments in the chronically inflamed areas. After 15 days recovery was
seen and only focal hyperplasia of the epithelium was seen in some air sacs and
O. rhinotracheale c lls or fragments could be found sporadically.
Figure 2. Immuno-histo-
chemistry on the air sac of a
chicken, 1 day post O.
rhinotracheale exposure
without ND treatment. The
brown spots indicate O.
rhinotracheale c lls or
fragments attached to cilia
of the epithelium on the
respiratory side. A mild
infiltration of the epithelium
by PMN’s can be seen. Bar
= 10 µm.
Figure 3. Immuno-histo-
chemistry on the air sac of a
chicken, 2 days post O.
rhinotracheale exposure
with ND treatment. The
brown spots indicate O.
rhinotracheale c lls or
fragments attached to the
respiratory epithelium and
associated to inflammatory
cells in the lumen of the air
sac. Also infiltration of the
epithelium by PMN’s and
macrophages can be seen. Bar = 50 µm.
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Figure 4. The air sac of
a chicken, 2 days post O.
rhinotracheale exposure
with ND treatment.
Haematoxylineosin stain.
Infiltration of the air sac
epithelium by PMN’s and
macrophages can be seen
with presence of inflam-
matory cells in the air sac
lumen. Bar = 50 µm.
Figure 5. Immuno-histo-
chemistry on the air sac of a
chicken, 4 days post O.
rhinotracheale exposure
with ND treatment. The
brown spots indicate
O. rhinotracheale c lls or
fragments located within
the air sac underneath the
epithelium causing acute
granulomatous airsaccilitis.
Bar = 50 µm.
Figure 6. Immuno-histo-
chemistry on the air sac of a
chicken, 5 days post O.
rhinotracheale exposure
with ND treatment. The
brown spots indicate
O. rhinotracheale c lls or
fragments located deep in
the air sac tissue, associated
to single and accumulated
macrophages. Bar = 50 µm.
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Figure 7. The lung of a
chicken, 5 days post
O. rhinotracheale exposure
with ND treatment.
Haematoxylin-eosin stain.
In the center an infected
BALT-area with infiltration
by bacteria and necrosis of
the tissue can be seen. On
the left side a negative
BALT-area is shown.
Bar = 50 µm.
Figure 8. Immuno-histo-
chemistry on the lung of a
chicken, 5 days post
O. rhinotracheale exposure
with ND treatment. The
brown spots indicate
O. rhinotracheale c lls or
fragments located in an
infected BALT-area.
Bar = 50 µm.
DISCUSSION
When given to susceptible birds post ND priming, O. rhi otracheale was shown
to be invasive in the air sacs and lungs. By immunohistochemistry we could clearly
prove that O. rhinotracheale was the cause of the induced inflammations. At 2 days
post O. rhinotracheale exposure, the air sacs showed infiltration of the epithelium
by macrophages and PMN’s. Then the air sacs thickened, oedematous and
granulomatous tissue was formed and a strong accumulation of macrophages at the
site of infection was seen. O. rhinotracheale c lls or fragments were demonstrated
all over the airsacs but predominantly associated with macrophages. The airsacculitis
peaked between 5 and 9 days post exposure and lateron recovery was seen. Some of
the BALT-areas within the lungs showed lesions attributed to O. rhinotracheale
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approx. 4 to 5 days post exposure and O. rhi otracheale ntigen could be demonstrated
within these lesions. No other organs became affected and O. rhinotracheale c lls or
fragments could not be found in any other investigated organ.
This immuno-histochemical investigation confirms the finding in a previous
clinical study (13), that aerosol exposure of chickens with O. rhinotracheale without
(viral) priming will not result in significant lesions of the respiratory tract. In non
primed birds only minimal and temporary microscopic air sac lesions could be induced
with focal attachment of the bacteria to the epithelium. Both immuno-histochemically
and bacteriologically, O. rhinotracheale could not be recovered anymore at time
points later than two days post aerosol exposure. This seems in contradiction with
the fact that serologically the O. rhinotracheale exposure without ND-treatment
resulted in a longstanding and high response, equal to the response found in the
heavily infected birds out of the group which was exposed to O. rhinotracheale after
ND priming. In contrast with serological results of fieldsera from birds with known
O. rhinotracheale infections whose titres decreased substantially within 6 - 10 weeks
(personal observations, not published), the serological responses remained at the
same level up to at least 14 weeks post O. rhinotracheale exposure. In the field we
regularly found that both the serological response and the bacteriological recovery
of the bacterium decreased rapidly after an O. rhinotracheale infection. An explanation
for this difference could be that the way of exposure used in this challenge test, very
fine aerosol containing high amounts of viable bacteria, allows the bacterium to
enter the respiratory tract of the bird far better compared to exposure in the field. But
even then the high and longstanding serological responses indicate that the bacterium
should be invasive somewhere else in the body or capable to induce the immune-
system in another way. We were only able to detect O. rhinotracheale bacteria or
bacterial fragments in the respiratory tract but not in any other part of the infected
birds but the method used might not be sensitive enough. If the bacterium is hiding
itself somewhere in the body more sensitive detection methods, such as PCR, should
be developed to find the place of concealment.
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SUMMARY
Vaccination of young broilers against experimental O. rhi otracheale challenge
was found to be effective but the results of vaccination were influenced in a negative
way by the presence of maternal antibodies. The use of a strong adjuvant, such as
mineral-oil, in a bacterin was necessary to obtain good protection when maternal
antibodies were present.
Vaccination of broiler-breeders resulted into high serological responses and
protection of their progeny against experimental O. rhi otracheale challenge up to
an age of 4 weeks.
Vaccination of broilers with a live vaccine was found to be effective when the
maternal antibody-levels were low. A combination of vaccinating the breeders with
a bacterin and their progeny with a live vaccine at approx. 3 weeks of age seems to
be the best way to protect broilers against O. rhi o racheale infection.
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INTRODUCTION
Ornithobacterium rhinotracheale is found to be able to cause respiratory disease
in turkeys and chickens (1,2,3,6,7,8,9,10,11,12). Clinically the isolation of O. rhino-
tracheale could be connected to weakness, gasping, severe dyspnoea, mucus dis-
charge, weight-gain losses and increased mortality rates. Dissection of diseased birds
showed fibrinopurulent, often unilateral, pneumonia and fibrinous inflammation of
the air sacs (11). Up to now 7 different serotypes, designated A - G, were reported
(14) but recently 2 more serotypes were found, serotypes H and I (own observation,
not published). The most predominant serotype is type A. In chickens, more than 95
% of the isolates are found to be of serotype A (14).
Experimentally the disease could be evoked by aerosol administration of O. rhino-
tracheale, but only as a secondary infection after the administration of primers. As
viral primers Turkey rhinotracheitis virus and Newcastle Disease virus (ND) can be
used for turkeys while ND and Infectious Bronchitis virus can be used for chickens
(13). Also Escherichia coli (5) and Bordetella avium (4) were found to have a
triggering effect on O. rhinotracheale infections.
In this study we investigated the influence of vaccination on experimental O.
rhinotracheale infections in broiler chickens, using serotype A vaccines. Normally
broilers only will come in hand at one day of age so vaccinations with inactivated
vaccine were performed on one-day-old birds. Because maternal antibodies regularly
were found in the field (14), the influence of these antibodies on vaccine efficacy
was investigated by comparing vaccination results in one-day-old commercial broilers
(with maternal antibodies) with the vaccination results in older SPF (= special pat-
hogen free) birds (without antibodies at time of vaccination). Also it was investigated
if vaccination of broiler-breeders will induce protection in their progeny against
experimental O. rhinotracheale challenge. Finally, the feasibility of live vaccination
was investigated in young broilers.
MATERIALS AND METHODS
Bacterial strains. The O. rhinotracheale s rotype A strains used for this study
were strain B3263/91 (isolated out of a diseased broiler chicken in South Africa by
J.H. duPreez) and strain BAC 96-0034 (isolated out of a broiler chicken in Delaware,
USA by E. Odor; originally designated as 95-1339). For the live vaccine, strain
B3263/91 was passed in vitro 35 times (B3263/91/35). The strains were maintained
lyophilized at -20°C. Bacteria were grown at 37°C on sheepbloodagar plates in a 5-
10% CO2 atmosphere or in Todd Hewitt broth (THB) at 37°C.
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Vaccines. Inactivated vaccines were bacterins, produced from strain B3263/91, with
3 different adjuvants (mineral-oil, corn-oil or saponin), containing ± 1 x 109 cells per
dose. Vaccinations were performed by injecting 0.25 ml subcutaneously in the neck.
For live vaccinations, 100 ml of THB-cultures of O. rhinotracheale strain B3263/91/35,
containing between 1 x 108 and 1 x 109 colony forming units (CFU) per ml, were
administered as a fine spray to the birds in an isolater of ± 1.5 m3, using a co mercial
paint sprayer. The developed mist in the isolaters was maintained for at least 10 min. with
the air circulation closed.
Experimental animals. Chickens used were commercial broiler-breeders and broilers
or special pathogen free (SPF) white leghorns. The broilers and SPF leghorns did arrive
as embryonated eggs and were housed in isolaters immediately after hatch. The broiler-
breeders were purchased at an age of 11 weeks. Food (Hendrix, Boxmeer, the Netherlands)
and water were given ad libitum to the broilers and SPF leghorns but on ratio to the
broiler-breeders. The broilers and SPF leghorns did not receive any other vaccination or
treatment during the experiments. The broiler-breeders were vaccinated according to the
schedule of the supplier.
Challenge. O. rhinotracheale challenge was performed as described before (13).
Briefly : Five or six days before the O.rhinotracheale challenge the chickens were treated
with a coarse spray of a culture of a lentogenic ND virus, strain LaSota, containing at
least 106 median egg infective doses per bird. Aerosol O. rhinotracheale challenges were
performed with THB cultures of strain BAC 96-0034, containing between 1 x 108 and 1
x 109 CFU per ml, which were given as an aerosol in the same way as the live vaccine
was applied.
Parameters of infection. Post-mortem investigations were performed 7 days post
challenge and lesions were scored. Airsacculitis was scored for the thoracic and the
abdominal airsacs separately. The thoracic airsacs were scored : 0 = no abnormalities, 1
= one airsac seriously affected by fibrinous airsacculitis or limited pinhead-sized foci of
fibrinous exudate in both air sacs, 2 = both air sacs seriously affected by fibrinous
airsacculitis. The abdominal air sacs were scored : 0 = no abnormalities, 1 = pinhead-
sized foci of fibrinous exudate or slight diffuse airsacculitis, 2 = severe fibrinous
airsacculitis. The airsacculitis score is given as the sum of both scores. Pneumonia was
scored : 0 = no abnormalities, 1 = unilateral pneumonia, 2 = bilateral pneumonia. The
average group-scores are given as a percentage of the maximal possible score. Statistical
analysis was performed using the Kruskal-Wallis test.
Serology. Bloodsamples were tested in an enzyme-linked immunosorbent assay
(ELISA) against antigens of O. rhinotracheale strain B3263/91 as previously described
(14).  All sera were prediluted 1:16. Statistical analysis was performed using the Students-
t test.
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EXPERIMENTAL DESIGN
Experiment 1. Ten one-day-old broilers per group were vaccinated with one of the 3
different bacterins. ND was administered at 21 days of age, O.rhinotracheale- challenge
was performed at 26 days of age and post-mortem investigation was performed at 33
days of age. Ten, not vaccinated, birds per group were used as negative controls, controls
for ND administration or challenge controls.
Experiment 2. Ten SPF leghorns per group were vaccinated at an age of 21 days with
one of the 3 different bacterins. In this experiment it was chosen to use 3-weeks-old SPF
birds to minimilize the chance of the presence of antibodies at time of vaccination. ND
was administered at 42 days of age, O.rhinotracheale challenge was performed at 48
days of age and post-mortem investigation was performed at 56 days of age. Ten, not
vaccinated, birds per group were used as negative controls, controls for ND administration
or challenge controls.
Experiment 3. At 12 and 18 weeks of age, 25 broiler-breeders were vaccinated  with
the bacterin in mineral-oil-adjuvant and 25 broiler-breeders were kept as not vaccinated
controls. At the age of 32 and 37 weeks from both groups of broiler-breeders embryonated
eggs were collected and broilers were hatched. From all groups 10 broilers were treated
with ND at 9 days of age, challenged with O. rhinotracheale at 15 days of age and post-
mortem investigations were performed at 22 days of age. From the not vaccinated breeder
group, 10 broilers were used as negative controls and 10 broilers were used as controls
for ND administration. From both breeder groups 10 broilers, hatched out of eggs layed
at a breeder-age of 37 weeks, were treated with ND LaSota at 24 days of age, challenged
with O. rhinotracheale t 30 days of age and post-mortem investigations were performed
at 37 days of age. From the not vaccinated breeder group, 10 broilers were used as
negative controls and 10 broilers were used as controls for ND administration.
Experiment 4. Seventeen one-day-old, 19 seven-days-old and 20 fourteen-days-old
broilers were vaccinated with live vaccine. Seventeen one-day-old, 21 seven-days-old
and 15 fourteen-days-old broilers from the same hatches were kept as not vaccinated
controls. Seven days post vaccination, 5 birds from each group were sacrificed and a
post-mortem investigation was performed to see if any pathology was induced by the
vaccination. To the remaining birds ND was administered 7 days post vaccination, O.
rhinotracheale challenge was performed 14 days post vaccination. Post-mortem
investigation was performed 21 days post vaccination.
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RESULTS
Experiment 1. The results of this experiment are listed in Table 1. The average
ELISA titre (in 2log) against O. rhinotracheale s rotype A in the blood of the one-
day-old broilers, used in this experiment, was 8.9 (± 1.0). Good protection and a
moderate serological response was measured in the birds vaccinated with the bacterin
in mineral-oil-adjuvant. The bacterin in saponin-adjuvant induced a low protection
and a minimal serological response, whereas the bacterin in corn-oil-adjuvant hardly
showed any response or protection.
       Table 1: Post-mortem results of experiment 1 (Inactivated O. rhinotracheale
vaccines in broilers). Vaccination at day 1, ND administration at day 21, challenge at
day 26, post-mortem at day 33.
avg. ELISA titre            lesion-scores in % of
                    Group (in 2log)              the maximal possible score
Treatment N at age of challengeAirsacculitis Pneumonia
Mineral-oil-adjuvant10 8.4 (±1.8)a 15%a 0%a
Corn-oil-adjuvant 10 5.4 (±0.9)bc 85%c 5%a
Saponin-adjuvant 10 6.2 (±1.1)b 65%b 15%ab
Challenge controls 10 4.1 (±0.5)c 95%c 35%bc
ND controls 10 4.3 (±0.7)c 10%a 0%a
Negative controls 10 4.1 (±0.3)c 5%a 0%a
Within columns, values having different superscripts are significantly different (p<0.05)
Experiment 2. The results of this experiment are listed in Table 2. No antibodies
were detected in the blood of the 21 days old SPF leghorns, used in this experiment.
Good protection and a very high serological response was measured in the birds
vaccinated with the bacterin in mineral-oil-adjuvant. The bacterin in saponin-adjuvant
induced a significant decrease of lesions and a moderate serological response, whereas
the bacterin in corn-oil-adjuvant showed the lowest response or protection.
Experiment 3. The average serological responses after vaccination of the broiler-
breeders against O. rhinotracheale s rotype A, which declined slightly but remained
rather stable during the course of this experiment, are shown in Figure 1. The kine-
tics of antibody titres in the hatched broilers are shown in Figure 2. The challenge
results of the broilers are listed in Table 3. Moderate levels of antibodies against O.
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rhinotracheale serotype A were measured in the breeders at time of vaccination
(average titre of 9.7 ± 1.2). The first vaccination already boosted the serological
responses to very high levels, which did not increase after the second vaccination
(Fig. 1).
       Table 2 : Post-mortem results of experiment 2 (inactivated O. rhinotracheale
vaccines in SPF leghorns). Vaccination at day 21, ND administration at day 42,
challenge at day 48, post-mortem at day 56.
avg. ELISA titre            lesion-scores in % of
                    Group (in 2log)              the maximal possible score
Treatment N at age of challengeAirsacculitis Pneumonia
Mineral-oil-adjuvant10 18.0 (±2.4)a 22.5%a 5%a
Corn-oil-adjuvant 10 7.1 (±2.0)b 45%b 5%a
Saponin-adjuvant 10 9.1 (±1.7)b 37.5% b 0%a
Challenge controls 10 Not tested 65%c 30%b
ND controls 10 Not tested 20%a 0%a
Negative controls 10 £ 4.0c 0%d 0%a
Within columns, values having different superscripts are significantly different (p<0.05)
Figure 1. Average serological response of broiler-breeders against O. rhino-
tracheale serotype A. Breeders were vaccinated with O. rhinotracheale strain B3263/
91 bacterin in mineral-oil-adjuvant at 12 and 18 weeks of age. n = vaccinated group;
o = control group.
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Figure 2. Average O. rhinotracheale s rotype A titres of broilers, hatched from
eggs layed by 37 weeks old breeders. Breeders were vaccinated with O. rhinotracheale
strain B3263/91 bacterin in mineral-oil-adjuvant at 12 and 18 weeks of age.
n = broilers out of eggs layed by the vaccinated group; o = broilers out of eggs
layed by the control group.
Vaccination of broiler-breeders with a bacterin in mineral-oil-adjuvant did induce
enough maternal antibodies in their progeny to give good protection against challenge
with O. rhinotracheale at 14 days of age and still a significant protection at 30 days
of age (Table 3).
Experiment 4. The live vaccine strain did not induce any disease as judged at the
post-mortem investigation of vaccinated birds seven days post vaccination. The results
with regard to antibody responses and protection are shown in Table 4. Maternal
antibodies were measured at one day of age. Live vaccination of one-day-old broilers
did not induce a significant protection against experimental O. hinotr cheale
infection and the serological response was low and not significant. Vaccination at 7
days of age induced a significant protection and serological response. A very good
protection was obtained by the vaccination at 14 days of age.
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DISCUSSION
In the experiment in which one-day-old broilers were vaccinated and where
moderate antibody titres were found at time of vaccination, the vaccine in mineral-
oil-adjuvant was the only vaccine able to induce good protection. This in spite of the
low to moderate serological response at time of challenge. The same vaccine was
able to induce good protection and very high antibody titres, when used in birds
whithout antibodies at time of vaccination, as proven in the experiment with 3-weeks-
old SPF leghorns. As compared with the mineral-oil vaccine, poor protection was
induced by the corn-oil and saponin based vaccines but it appeared that these vaccines
performed relatively better in leghorns without antibodies at time of vaccination
than in broilers in which antibodies were present at time of vaccination. Furthermore,
the results with the live vaccine showed that serological and protective responses
increased with age at vaccination and with decrease of maternal antibody levels at
time of vaccination. These results might indicate that maternal antibodies have a
negative influence on vaccine efficacy of non-mineral-oil vaccines, although at pre-
sent also a difference in immunocompetence between the chickens used in the various
experiments can not be excluded.
Only the mineral-oil-adjuvant was found to give a good protection in young birds
even when maternal antibodies were present. However, a disadvantage of vaccinating
one-day-old birds with bacterins in mineral-oil-adjuvants is that the vaccination on
its own can have a negative effect on the performance of the birds and induce local
tissue reactions. Out of these findings one can conclude that vaccination of one-day-
old broilers in the field, where maternal antibodies are widespread and therefore a
mineral-oil-adjuvant will be needed, only will be considered in case of emergency.
This means that another strategy should be followed to prevent O. rhinotracheale
infections in broilers.
In the vaccination experiment of broiler-breeders it was found that the bacterin in
mineral-oil-adjuvant induced high and longstanding responses in the broiler-breeders.
The serological response at the start of the experiment, the strong serological res-
ponse after the first vaccination and the lack of booster effect after the second
vaccination support the idea that most probably the flock already had been in contact
with O. rhinotracheale. If so, it means that the first vaccination already reacted as a
booster on the former infection, indicating that two vaccinations will be needed in
breeders that had not been in contact with O. rhinotracheale b fore the vaccination.
The vaccinations induced high levels of maternal antibodies in the progeny resulting
in good protection against experimental challenge of the hatched broilers at an age
up to 30 days of age. However, protection decreased with increasing age of the broilers,
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since protection at 15 days was better than protection at 30 days of age. As mentioned
before, the efficacy of live vaccination of broilers increased with the age at time of
vaccination. Therefore, the most practical approach in combating O. rhinotracheale
infections in broilers seems to be breeder vaccination with an inactivated vaccine
combined with live vaccination of broilers at 2-3 weeks of age. However, the efficacy
of live vaccination of broilers hatched from vaccinated breeders still needs to be
determined.
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GENERAL DISCUSSION AND CONCLUSIONS
The objective of the research discribed in this thesis was to investigate the bacterium
Ornithobacterium rhinotracheale, the disease it is causing in fowl, the epidemiology
and the possible ways of prevention of the disease.
O. rhinotracheale has been isolated from several bird-species with respiratory
infections in different parts of the world. The cause of the disease was hard to determine
because the isolation of O. rhinotracheale is problematic, especially since O.
rhinotracheale is often overgrown by other bacteria. Therapeutic treatment of the disease
was found to be difficult and sometimes even impossible because many O.
rhinotracheale strains are resistant to the regularly used antibiotics. Economic losses
are hard to estimate because the disease is often just slumbering with increased mortality
rates of 2 - 10% and growth retardation which is difficult to determine. Only in older
turkeys losses are dramatic with mortality rates up to 50% in a few days.
The first goal of this study was to fulfil the three postulates of Koch and thus prove
that O. rhinotracheale is capable to cause the disease seen in the field. Experiments
with O. rhinotracheale alone, in which several challenge-routes were investigated,
revealed only growth retardation but no visible respiratory infections. However, when
birds were treated with avian respiratory viruses prior to an aerosol infection with O.
rhinotracheale, the bacterium was found to be able to induce growth retardation as
well as airsacculitis and pneumonia in both chickens and turkeys (Chapter 2). Clinically
the features of this infection were identical to those observed in the field. Later on,
with use of the immuno-histochemical peroxidase-anti-peroxidase (PAP) staining, we
proved beyond any doubt that O. rhinotracheale, and not the virus, was the cause of
the lesions in the air sacs (Chapter 4B). With the same method it could be proven that
a (viral) trigger is needed to induce lesions in air sacs and/or lungs caused by O.
rhinotracheale. Without the trigger, using the same challenge dose, O. rhin tracheale
was not infectious and could not been demonstrated at time points later than 2 days
post challenge (Chapter 4B).
Not only viruses but also bacteria such as E cherichia coli (3) and Bordetella avium
(2) are able to trigger an O. rhinotracheale infection. Up to now only one report is
known in which O. rhinotracheale was found to be pathogenic after intratracheal
inoculation in 22 weeks old turkeys without a second infection in the birds (4). Because
the immune status of the birds in this study was not known, nor the possible presence
of agents able to trigger O. rhinotracheale infections, we can not conclude from these
studies that O. rhinotracheale is a primary pathogen.
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The second goal was to prove that O. r inotracheale, which had not yet been named
by that time, is a new bacterial species that is pathogenic for fowl. Therefore growth
conditions had to be optimized, a reasonable number of field strains had to be collected
and the necessary tests had to be performed to distinghuish O. rhinotrac eale from
other bacterial species with which it could be confused. It could be proven biochemically
and serologically that O. rhinotracheale was a new bacterial species and a new fowl
pathogen (Chapter 3A). Vandamme et al. (5) provided genetic vidence for this new
species and proposed the name of the bacterium. In total about 1100 strains were
investigated biochemically and serologically. As result of these studies an identification
method could be developed which appeared to be highly specific and practical (Chapter
3A). Another result was that, up to now, 9 different serotypes of O. hinotracheale can
be distinghuished (Chapters 3A and 3B).
Investigation of the genomic DNA of selected strains by amplified fragment length
polymorphism gave an indication for the existence of more subspecies within O. rhino-
tracheale or even new species within the genus Ornithobacterium (Chapter 3B). In
contrast to these findings, results of other studies, such as PCR (1, Chapter 3B), cellular-
protein profiles (5) and outer-membrane-protein profiles (Chapter 3B), show that the
reactions of the O. rhinotracheale strains investigated were very homogeneous. More
study will be required to clarify these contradictions. Nevertheless it seems that O.
rhinotracheale was only recently introduced into domestic poultry and that the isolates
recovered throughout the world belong to a small group of closely related clones.
The third goal was to learn more about the disease and the infection route. During
the infection studies indications were found that O. rhinotracheale can be transmitted
via eggs. This could be the explanation for the global spread of O. rhinotracheale
within a few years, since eggs are distributed worldwide. Egg-transmission was
demonstrated by hatching eggs from suspected flocks. The hatched birds were kept in
isolation and treated with viruses that had been proven to be able to trigger O.
rhinotracheale infections. O. rhinotracheale was isolated from air sacs of such birds
(Chapter 4A). O. rhinotracheale could also be isolated, although sporadically, from
egg-shells and yolk-sacs of one-day-old birds (Chapter 4A).
The possibility of egg-transmission together with the fact that almost all O.
rhinotracheale can be placed in a small group of closely related clones and the fast
global spread of the disease, supports the idea that the bacterium is a new mutant or
that the bacterium was only recently introduced into the domestic poultry population
e.g. from wild birds.
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The course of the respiratory disease could be followed with the histo-
immunochemical PAP-staining (Chapter 4B). After a viral priming, O. rh notracheale
was found to infiltrate the epithelium of the air sacs and to cause an acute granulomatous
airsacculitis. Also an infiltration of some, but not all, parts of the bronchial associated
lymphoid tissue in the lungs by O. rhinotracheale could be demonstrated. O.
rhinotracheale cells or cell-fragments were often associated with macrophages. The
disease peaked 5 - 9 days post challenge, after which birds recovered fast. The bacterium
was not demonstrated in other tissues than those of the respiratory tract.
Without viral priming, O. rhinotracheale disappeared within two days after challenge
but the serological reactions in these birds were as strong and longlasting as those
found in heavily infected birds (Chapter 4B). This means that O. rhinotr cheale may
hide somewhere else in the body or that it stimulates the immune-system in another
way. If O. rhinotracheale can invade cells (e.g. macrophages, where most of the reaction
was found with the immuno-histochemical staining), even without viral priming than
there is a good chance that O. rhinotracheale is able to survive intracellularly. In this
way the bacterium could hide itself somewhere in the body. This may also explain how
O. rhinotracheale causes infections, as soon as the immune-system is suppressed, or
tissues are damaged e.g. by a virus.
The fourth goal was to prevent infections caused by O. rhinotracheale. The result
of vaccination of one-day-old broiler-chickens with bacterins was found to depend on
the kind of adjuvant used (Chapter 5). Only vaccines in mineral-oil-adjuvant showed
good protection. The other adjuvants tested were not able to induce a reasonable
protection, most probably due to the maternal antibodies which are detected in almost
all tested commercial birds.  This poses a problem since the use of mineral-oil-adjuvants
is known to have negative effects on the broilers.
Vaccination of broiler-breeders with a bacterin of O. rh otracheale in mineral-oil-
adjuvant resulted in high and long lasting protection and serological responses (Chapter
5). A good protection of the progeny of these animals against experimental challenge
with O. rhinotracheale was also observed. Protection of broilers, hatched from eggs
layed by vaccinated broiler-breeders, lasted up to about 4 weeks of age, then it decreased.
Live vaccination of young broilers with O. rhinotracheale was found to be feasible
(Chapter 5). The protection against experimental challenge with O. rhinotracheale
increased with the age at time of vaccination and was negatively related to the amount
of maternal antibodies.
The conclusion of the vaccination trials sofar is that vaccination of one-day-old
broilers will not be feasible, exept for emergency cases where mineral-oil-adjuvant
bacterins can be of use in spite of the possible local tissue reactions. The best approach
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to prevent infections of O. rhinotracheale in broilers is vaccination of broiler-breeders
with an inactivated vaccine in combination with live vaccination of broilers at 2 to 3
weeks of age. The same strategy can be used for turkeys, although, because turkeys are
handled at older ages, it may also be possible to use inactivated vaccines with other
adjuvants at 2 to 3 weeks of age.
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Samenvatting
Het doel van de in dit proefschrift beschreven studie was het onderzoeken van de
bacterie Ornithobacterium rhinotracheale, de ziekte die deze bacterie veroorzaakt,
de epidemiologie van de ziekte en de preventie van de ziekte. Bij de start van het
onderzoek was er nog niets bekend over de bacterie en het ziektebeeld. De eerste
berichten over luchtwegaandoeningen in pluimvee, veroorzaakt door een nog niet
geïdentificeerde Pasteurella- chtige bacterie kwamen uit Zuid Afrika in 1991, waar
de bacterie uit ontstoken luchtzakken van mestkuikens geïsoleerd kon worden. Na-
der onderzoek leerde dat deze bacterie, biochemisch zowel als uiterlijk, grote over-
eenkomst vertoonde met een bacterie die in 1987 geïsoleerd was uit een eend met
longontsteking in Hongarije en een bacterie die begin 1992 geïsoleerd was uit een
ontstoken luchtzak van een kalkoen.
Het leveren van het bewijs dat O. rhinotracheale d veroorzaker van de lucht-
weg-aandoeningen in pluimvee was werd de eerste doelstelling. Hiervoor werden
besmettings-proeven in kippen en kalkoenen uitgevoerd, waaruit bleek dat de bacte-
rie op zichzelf het ziektebeeld niet kon opwekken. Pas nadat een dier behandeld was
met virussen, die in staat zijn lichte luchtwegaandoeningen in pluimvee op te wek-
ken, kon met een aerosol toediening van O. rhinotracheale h t ziektebeeld geinduceerd
worden. Later kon met behulp van een immuno-histochemische kleuring onomstote-
lijk worden bewezen dat O. rhinotracheale d  veroorzaker van de luchtweg infectie
was en dat de virale behandeling vooraf noodzakelijk was voor het opwekken van
het ziektebeeld.
Als tweede doel werd gesteld dat bewezen moest worden dat O. rhinotracheale
een nieuw bacterie-species en/of een nieuwe pathogeen voor pluimvee was. Nadat
de groei condities geoptimaliseerd waren kon, serologisch zowel als biochemisch,
worden bewezen dat O. rhinotracheale niet behoorde tot een bekend bacterie-spe-
cies of pluimvee-pathogeen. Door anderen is dit ook genetisch bewezen en werd de
naam Ornithobacterium rhinotracheale aan de bacterie gegeven. Er werd een stam-
men collectie opgezet en met behulp daarvan werd een identificatie methode ont-
wikkeld en konden 9 serotypes onderscheiden worden.
Onderzoek naar het DNA van relevante stammen wees uit dat er de mogelijkheid
bestaat dat O. rhinotracheale onderverdeeld kan worden in subspecies of zelfs dat
het genus Ornithobacterium onderverdeeld dient te worden in verschillende species.
Echter andere testen, zoals PCR en het bepalen van het eiwit-patroon van de buiten
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membranen, gaven een grote homogeniteit binnen de onderzochte stammen aan. Dit
laatste wijst erop dat O. rhinotracheale e n recente mutant is of dat de bacterie
slechts kortgeleden, via bijvoorbeeld contact met wild gevogelte, geïntroduceerd is
in de commerciele pluimvee wereld.
De derde doelstelling was het in kaart brengen van de infectie route en een beter
inzicht krijgen over de manier hoe O. rhinotracheale d  infectie veroorzaakt. Er kon
worden aangetoond dat, naast de route via de lucht, O. rhinotracheale, en daarmee ook
de ziekte, ook via het ei kan worden overgebracht. Dit verklaart waarschijnlijk de
snelle verspreiding van de ziekte (binnen enkele jaren werd de bacterie in 4 continen-
ten aangetroffen) omdat bevruchte eieren over de hele wereld verstuurd worden.
Een experimenteel opgewekte infectie werd bacteriologisch en serologisch gevolgd
en het ontstaan van het ziektebeeld werd bekeken met behulp van een immuno-
histochemische methode. Hieruit kwam naar voren dat O. rhi otracheale waarschijn-
lijk in staat is op een schuilplaats binnen het lichaam van het dier te overleven van
waaruit hij, na bijvoorbeeld een virale infectie, het ziektebeeld kan op wekken.
De vierde doelstelling was het voorkomen van de ziekte, veroorzaakt door O.
rhinotracheale, door middel van vaccinatie. Het succesvol vaccineren met bacterins
bleek afhankelijk van het soort adjuvant dat gebruikt werd. Ook bleek de aanwezig-
heid van (maternale) antistoffen te interfereren met de vaccinatie, hoe meer antistoffen
er aanwezig waren op het tijstip van vaccinatie hoe minder bescherming er geinduceerd
werd. Het vaccineren van eendags mestkuikens was alleen succesvol als er een mine-
rale olie als adjuvant gebruikt werd. Maar, omdat vaccinatie met vaccins in minerale
olie op zichzelf al schadelijke gevolgen voor het dier kan hebben, zoals lokale ent-
reacties en groeiachterstand, zal vaccinatie met dit vaccin alleen in noodgevallen in
eendags kuikens gebruikt kunnen worden.
Vaccinatie van mestkuiken-moederdieren was succesvol m.b.t. de bescherming van
de nakomelingen van gevaccineerde dieren in de eerste weken van hun leven. Het
reduceren van de spreiding van O. rhi otracheale, bijvoorbeeld d.m.v. eieren, kon niet
bewezen worden omdat de incidentie van O. rhinotracheale laag en de isolatie zeer
moeilijk is.
Vaccinatie met levende O. rhinotracheale c llen induceerde een goede bescher-
ming in jonge mestkuikens. Ook hier bleek dat het resultaat van de vaccinatie afhanke-
lijk was van de hoeveelheid (maternale) antistoffen op het tijdstip van vaccinatie.
De combinatie van het enten van mestkuiken-moederdieren met een bacterin en
een levende vaccinatie van de mestkuikens op 2 - 3 weken leeftijd lijkt de beste me-
thode ter voorkoming van de ziekte in mestkuikens.
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